1
|
Basch CH, Hillyer GC, Basch CE. Wait Times for Scheduling Appointments for Prevention of Macrovascular and Microvascular Complications of Diabetes: Cross-Sectional Descriptive Study. J Med Internet Res 2024; 26:e55351. [PMID: 38530352 PMCID: PMC11005437 DOI: 10.2196/55351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2023] [Revised: 01/30/2024] [Accepted: 02/13/2024] [Indexed: 03/27/2024] Open
Abstract
BACKGROUND Diabetes is a chronic disease that requires lifelong management and care, affecting around 422 million people worldwide and roughly 37 million in the United States. Patients newly diagnosed with diabetes must work with health care providers to formulate a management plan, including lifestyle modifications and regular office visits, to improve metabolic control, prevent or delay complications, optimize quality of life, and promote well-being. OBJECTIVE Our aim is to investigate one component of system-wide access to timely health care for people with diabetes in New York City (NYC), namely the length of time for someone with newly diagnosed diabetes to obtain an appointment with 3 diabetes care specialists: a cardiologist, an endocrinologist, and an ophthalmologist, respectively. METHODS We contacted the offices of 3 different kinds of specialists: cardiologists, endocrinologists, and ophthalmologists, by telephone, for this descriptive cross-sectional study, to determine the number of days required to schedule an appointment for a new patient with diabetes. The sampling frame included all specialists affiliated with any private or public hospital in NYC. The number of days to obtain an appointment with each specialist was documented, along with "time on hold" when attempting to schedule an appointment and the presence of online booking capabilities. RESULTS Of the 1639 unique physicians affiliated with (private and public) hospitals in the 3 subspecialties, 1032 (cardiologists, endocrinologists, and ophthalmologists) were in active practice and did not require a referral. The mean wait time for scheduling an appointment was 36 (SD 36.4; IQR 12-51.5) days for cardiologists; 82 (SD 47; IQR 56-101) days for endocrinologists; and 50.4 (SD 56; IQR 10-72) days for ophthalmologists. The median wait time was 27 days for cardiologists, 72 days for endocrinologists, and 30 days for ophthalmologists. The mean time on hold while attempting to schedule an appointment with these specialists was 2.6 (SD 5.5) minutes for cardiologists, 5.4 (SD 4.3) minutes for endocrinologists, and 3.2 (SD 4.8) minutes for ophthalmologists, respectively. Over 46% (158/341) of cardiologists enabled patients to schedule an appointment on the web, and over 55% (128/228) of endocrinologists enabled patients to schedule an appointment on the web. In contrast, only approximately 25% (117/463) of ophthalmologists offered web-based appointment scheduling options. CONCLUSIONS The results indicate considerable variation in wait times between and within the 3 specialties examined for a new patient in NYC. Given the paucity of research on wait times for newly diagnosed people with diabetes to obtain an appointment with different specialists, this study provides preliminary estimates that can serve as an initial reference. Additional research is needed to document the extent to which wait times are associated with complications and the demographic and socio-economic characteristics of people served by different providers.
Collapse
Affiliation(s)
- Corey H Basch
- Department of Public Health, William Paterson University, Wayne, NJ, United States
| | - Grace C Hillyer
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States
| | - Charles E Basch
- Department of Health Studies and Applied Educational Psychology, Teachers College Columbia University, New York, NY, United States
| |
Collapse
|
2
|
Beauchemin MP, DeStephano D, Raghunathan R, Harden E, Accordino M, Hillyer GC, Kahn JM, May BL, Mei B, Rosenblat T, Law C, Elkin EB, Kukafka R, Wright JD, Hershman DL. Implementation of Systematic Financial Screening in an Outpatient Breast Oncology Setting. JCO Clin Cancer Inform 2023; 7:e2200172. [PMID: 36944141 PMCID: PMC10530809 DOI: 10.1200/cci.22.00172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2022] [Accepted: 01/30/2023] [Indexed: 03/23/2023] Open
Abstract
PURPOSE Implementation of routine financial screening is a critical step toward mitigating financial toxicity. We evaluated the feasibility, sustainability, and acceptability of systematic financial screening in the outpatient breast oncology clinic at a large, urban cancer center. METHODS We developed and implemented a stakeholder-informed process to systematically screen for financial hardship and worry. A 2-item assessment in English or Spanish was administered to patients through the electronic medical record portal or using paper forms. We evaluated completion rates and mode of completion. Through feedback from patients, clinicians, and staff, we identified strategies to improve completion rates and acceptability. RESULTS From March, 2021, to February, 2022, 3,500 patients were seen in the breast oncology clinic. Of them, 39% (n = 1,349) responded to the screening items, either by paper or portal, 12% (n = 437) preferred not to answer, and the remaining 49% (n = 1,714) did not have data in their electronic health record, meaning they were not offered screening or did not complete the paper forms. Young adults (18-39 years) were more likely to respond compared with patients 70 years or older (61% v 30%, P < .01). English-preferring patients were more likely to complete the screening compared with those who preferred Spanish (46% v 28%, P < .01). Non-Hispanic White patients were more likely to respond compared with Non-Hispanic Black patients and with Hispanic patients (46% v 39% v 32%, P < .01). Strategies to improve completion rates included partnering with staff to facilitate paper form administration, optimizing patient engagement with the portal, and clearly communicating the purpose of the screening. CONCLUSION Systematic financial screening is feasible, and electronic data capture facilitates successful implementation. However, inclusive procedures that address language and technology preferences are needed to optimize screening.
Collapse
Affiliation(s)
- Melissa P. Beauchemin
- School of Nursing, Columbia University Irving Medical Center, New York, NY
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
| | - David DeStephano
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
| | - Rohit Raghunathan
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
| | - Erik Harden
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
| | - Melissa Accordino
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
- Division of Hematology/Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY
| | - Grace C. Hillyer
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY
| | - Justine M. Kahn
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
- Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY
| | - Benjamin L. May
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
| | - Billy Mei
- Clinical Information Technology Shared Resources, New York Presbyterian Hospital, New York, NY
| | - Todd Rosenblat
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
- Division of Hematology/Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY
| | - Cynthia Law
- Division of Hematology/Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY
| | - Elena B. Elkin
- Department of Health Policy and Management, Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY
| | - Rita Kukafka
- Department of Biomedical Informatics, Columbia University, New York, NY
| | - Jason D. Wright
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY
| | - Dawn L. Hershman
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
- Division of Hematology/Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY
| |
Collapse
|
3
|
Basch CH, Hillyer GC, Yalamanchili B, Morris A. How TikTok Is Being Used to Help Individuals Cope With Breast Cancer: Cross-sectional Content Analysis. JMIR Cancer 2022; 8:e42245. [PMID: 36472899 PMCID: PMC9768649 DOI: 10.2196/42245] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2022] [Revised: 11/10/2022] [Accepted: 11/27/2022] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND Acknowledging the popularity of TikTok, how quickly medical information can spread, and how users seek support on social media, there is a clear lack of research on breast cancer conversations on TikTok. There is a paucity of information on how these videos can advocate for those impacted by breast cancer as a means to provide support and information as well as raise awareness. OBJECTIVE The purpose of this cross-sectional content analysis was to describe the content of videos from the hashtag #breastcancer on TikTok. Content related to breast cancer support and coping, cancer education, and heightening the awareness of breast cancer early detection, prevention, and treatment was evaluated. METHODS This study included 100 of the most viewed TikTok videos related to breast cancer through June 30, 2022. Videos were excluded if they were not in the English language or relevant to the topic being studied. Content was deductively coded into categories related to video characteristics and content topics using a screener based on expert breast cancer information sheets. Univariable analyses were conducted to evaluate differences in video characteristics and content when stratified as advocating or not advocating for breast cancer (yes or no) support, education, and awareness. RESULTS The cumulative number of views of the videos included in this study was 369,504,590. The majority (n=81, 81%) of videos were created by patients and loved ones of individuals with breast cancer, and the most commonly discussed topic was breast cancer support (n=88, 88%), followed by coping with the myriad issues surrounding breast cancer (n=79, 79%). Overall, <50% of the videos addressed important issues such as body image (n=48, 48%), surgery (n=46, 46%), medication and therapy (n=41, 41%), or the stigma associated with a breast cancer diagnosis (n=44, 44%); however, in videos that were advocacy oriented, body image (40/62, 64% vs 8/38, 21%; P<.001), stigma associated with breast cancer (33/62, 53% vs 11/38, 29%; P=.02), and breast cancer surgery (36/62, 58% vs 10/38, 26%; P=.002) were discussed significantly more often than in videos that did not specifically advocate for breast cancer. CONCLUSIONS The use of videos to display health journeys can facilitate engagement by patients, family members, and loved ones interested in information about challenging conditions. Collectively, these findings highlight the level of peer-to-peer involvement on TikTok and may provide insights for designing breast cancer educational campaigns.
Collapse
Affiliation(s)
- Corey H Basch
- Department of Public Health, William Paterson University, Wayne, NJ, United States
| | - Grace C Hillyer
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States
| | - Bhavya Yalamanchili
- Department of Public Health, William Paterson University, Wayne, NJ, United States
| | - Aldean Morris
- Department of Public Health, William Paterson University, Wayne, NJ, United States
| |
Collapse
|
4
|
Lima SM, Nazareth M, Schmitt KM, Reyes A, Fleck E, Schwartz GK, Terry MB, Hillyer GC. Interest in genetic testing and risk-reducing behavioral changes: results from a community health assessment in New York City. J Community Genet 2022; 13:605-617. [PMID: 36227532 DOI: 10.1007/s12687-022-00610-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2022] [Accepted: 09/29/2022] [Indexed: 11/25/2022] Open
Abstract
Risk-based genetic tests are often used to determine cancer risk, when to initiate screening, and frequency of screening, but rely on interest in genetic testing. We examined overall interest in genetic testing for cancer risk assessment and willingness to change behavior, and whether these are affected by demographic or socioeconomic factors.We conducted a community needs health survey in 2019 among primary care and cancer patients, family members and community members in New York City. We used univariable analysis and relative risk regression to examine interest in genetic cancer risk testing and willingness to modify lifestyle behaviors in response to an informative genetic test.Of the 1225 participants, 74.0% (n = 906) expressed interest in having a genetic test to assess cancer risk. Interest in genetic testing was high across all demographic and socioeconomic groups; reported interest in genetic testing by group ranged from 65.0 (participants aged 65 years and older) to 83.6% (participants below federal poverty level). Among the 906 participants that reported interest in genetic testing, 79.6% were willing to change eating habits, 66.5% to change exercise habits, and 49.5% to lose weight in response to an informative genetic test result.Our study reveals that interest in genetic testing for cancer risk is high among patients and community members and is high across demographic and socioeconomic groups, as is the reported willingness to change behavior. Based on these results, we recommend that population-based genetic testing may result in greater reduction cancer risk, particularly among minoritized groups.
Collapse
Affiliation(s)
- Sarah M Lima
- Mailman School of Public Health, Department of Epidemiology, Columbia University, New York, NY, USA
| | - Meaghan Nazareth
- Mailman School of Public Health, Department of Epidemiology, Columbia University, New York, NY, USA
| | - Karen M Schmitt
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA
- Division of Community and Population Health, New York Presbyterian Hospital, New York, NY, USA
| | - Andria Reyes
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA
| | - Elaine Fleck
- Division of Community and Population Health, New York Presbyterian Hospital, New York, NY, USA
| | - Gary K Schwartz
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA
- Department of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY, USA
| | - Mary Beth Terry
- Mailman School of Public Health, Department of Epidemiology, Columbia University, New York, NY, USA
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA
| | - Grace C Hillyer
- Mailman School of Public Health, Department of Epidemiology, Columbia University, New York, NY, USA.
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
| |
Collapse
|
5
|
Beauchemin MP, DeStephano D, Raghunathan RR, Accordino MK, Hillyer GC, Kahn J, Law C, Harden E, Wright JD, Kukafka R, Hershman DL. Optimizing the implementation of systematic financial screening. J Clin Oncol 2022. [DOI: 10.1200/jco.2022.40.28_suppl.277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
277 Background: Implementation of routine financial screening is a critical step toward mitigating financial toxicity. Screening facilitates identification and intervention delivery. We evaluate the feasibility and acceptability of systematic financial screening in a large, urban, outpatient cancer center. Methods: We developed and implemented a stakeholder-informed process to systematically screen all patients with cancer for financial hardship and financial worry using two items from the Comprehensive Score for Financial Toxicity. Screening was completed by patients in English or Spanish on paper forms or through the patient electronic portal; all responses were entered into the electronic health record (EHR). Repeated measures were prompted through the EHR monthly. We evaluated the feasibility of the implementation by completion rates, mode of completion and follow-up completion rates; and identified key factors to optimize implementation strategies and improve sustainability through key stakeholder feedback from patients, clinicians and staff. Results: From 3/2021 – 3/2022, 3,500 patients were seen in the outpatient breast oncology clinic and thus, eligible for screening. Of these, 39% (1,349) responded, either by paper or portal, 12% (N = 437) preferred not to answer when checking in via the patient portal, and the remaining 49% (N = 1,714) did not have data in their EHR, meaning screening was not offered or they did not complete the paper forms. Of the 1,349 respondents, most (79%, N = 1,063) responded via portal. Repeated screening measures were completed by 42% (N = 563) more than once. By language preference, response rates were 46% (English), 28% (Spanish), and 29% (Other languages). Completion rates on paper were not sustained after the initial implementation and dropped significantly after 6/2021; this correlated with staffing shortages. After expanding capacity for patients to check-in using kiosks in clinic in 7/2021, completion rates increased 78% in the following 3 months. Significant financial hardship was endorsed by 51% (N = 694), and financial worry by 36% (N = 484). From stakeholder feedback, including patient interviews, components were identified to improve screening completion rates: partnering with staff to facilitate distribution of paper forms for patients who do not use the portal; optimizing patient engagement with the portal; partnering with the electronic health record vendor to ensure non-English access is optimized; and transparent communication to patients regarding the purpose of the screening and resources available. Conclusions: We demonstrate that implementation of systematic financial screening requires an inclusive approach to achieve acceptable and equitable response rates. Electronic data capture contributes to successful financial screening implementation, but inclusive procedures that address language and technology preferences are needed to optimize screening.
Collapse
Affiliation(s)
| | - David DeStephano
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
| | - Rohit R. Raghunathan
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
| | | | - Grace C. Hillyer
- Department of Epidemiology, Mailman School of Public Health; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
| | - Justine Kahn
- Columbia University Medical Center, New York, NY
| | - Cynthia Law
- Columbia University Medical Center, New York, NY
| | | | | | - Rita Kukafka
- Columbia University College of Physicians and Surgeons, New York, NY
| | | |
Collapse
|
6
|
Goel P, Edmonds MC, Lin S, Goodman KA, Smith CB, Hillyer GC, Bickell NA. Diversity, equity, and inclusion in cancer clinical trial enrollment: Laying the groundwork for a cancer center collaborative intervention through key informant interviews. J Clin Oncol 2022. [DOI: 10.1200/jco.2022.40.28_suppl.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
98 Background: Clinical trial (CT) participation rates in the US are about 8% overall. Although, Black, Indigenous and People of Color (BIPOC) are as willing to join CTs as Whites, they remain underrepresented. We will implement a multi-level intervention across 3 cancer centers in New York City by creating a collaborative pool of CTs for breast, prostate, and liver cancer, thereby increasing availability of trials for all, especially BIPOC populations. To lay the groundwork, we conducted a formative evaluation to identify constructs that can influence implementation of this intervention. Methods: We designed a semi-structured interview guide for key informants to ascertain barriers and facilitators of enrollment at 1 cancer center and its 2 community affiliates. 23 key informants including oncologists, research staff, informatics, nurses, and cancer center leadership were identified using a targeted approach, followed by snowball sampling. Interviews were recorded, transcribed, and analyzed using thematic analysis approach. Results: Facilitators of accrual include patient referrals from physician-investigators and their teams, and oncologists’ knowledge of open trials through tumor boards, disease focus groups, and research meetings. Major barriers to CT enrollment are gaps in trial portfolio, inadequate infrastructure (e.g., staffing, space, and time), and incentives (e.g., RVU-based reimbursements). Informants felt that for patients, financial toxicity, medical mistrust, inadequate health literacy, comorbidities, poor performance status, and language are reasons for low accrual. Physicians emphasized their willingness to refer patients out-of-institution for CTs but lacked knowledge of outside trials. Care coordination across sites and loss of revenue for home institution are system-level barriers to referral. Additionally, informants believed that patients’ willingness to seek trials at other institutions is influenced by their commute, unfamiliarity with a new system, insurance coverage, rapport with oncologist, and motivation. Conclusions: Involving key stakeholders, increasing physician awareness of open CTs, educating patients and addressing their concerns about CTs, improving access to bilingual materials and interpreters, standardizing care coordination and ensuring similar rates of referrals across institutions are key facilitators to implement a multi-level intervention to increase CT enrollment across a cancer center collaboration.
Collapse
Affiliation(s)
- Pakhi Goel
- Department of Environmental Medicine & Public Health, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Megan C. Edmonds
- Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Sylvia Lin
- Department of Population Health Sciences and Policy, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Karyn A. Goodman
- Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
| | | | - Grace C. Hillyer
- Department of Epidemiology, Mailman School of Public Health; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
| | - Nina A. Bickell
- Department of Population Health Science and Policy; The Tisch Cancer Institute; Division of General Internal Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
| |
Collapse
|
7
|
Basch CH, Hillyer GC, Jacques ET. Professionally Created Content Related to HPV Vaccination on TikTok. Front Digit Health 2022; 4:888302. [PMID: 35847414 PMCID: PMC9277560 DOI: 10.3389/fdgth.2022.888302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2022] [Accepted: 05/23/2022] [Indexed: 11/13/2022] Open
Abstract
Despite the protective abilities of the HPV vaccine, roughly half of adolescents in the United States have not completed the recommended HPV vaccine series. Professionals have taken to using social media platforms to encourage health behaviors such as receipt of the HPV vaccine. As such, the purpose of this study was to identify content created by professionals related to HPV on TikTok. This descriptive, cross-sectional study was conducted in January 2022 using the hashtag #HPV Vaccine to examine the 100 English language videos created by people who claimed to be health professionals. In addition to capturing metadata, each videos' content and subsequent comments were coded. Overall, 75.0% of the videos mentioned HPV-related cancer but few discussed vaccination as a cancer preventive measure (40.0%). More than half (52.0%) of the comments were neutral in tone and most focused on cancer (54.0%), alternative medicine (58.0%), and general questions about vaccination (62.0%). Comments about videos with greater numbers of “likes” more often mentioned cancer (85.0% vs. 46.3%, p = 0.002), the age at which to get vaccinated (70.0% vs. 41.3%, p = 0.02) and more frequently posed questions about vaccination (80.0% vs. 41.3%, p = 0.002) and cost and insurance coverage of vaccination (35.0% vs. 11.3%, p = 0.02) compared to videos with fewer “likes.” The power of provider information is paramount with HPV vaccine uptake. As providers increasingly create health messages on platforms such as TikTok, it is important that they remain aware of the potential for opposing or non-factual discourse.
Collapse
Affiliation(s)
- Corey H. Basch
- Department of Public Health, William Paterson University, Wayne, NJ, United States
- *Correspondence: Corey H. Basch
| | - Grace C. Hillyer
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, NY, United States
| | - Erin T. Jacques
- Department of Health and Human Performance, York College, Jamaica, NY, United States
| |
Collapse
|
8
|
Basch CH, Hillyer GC, Jacques ET. News Coverage of Colorectal Cancer on Google News: Descriptive Study. JMIR Cancer 2022; 8:e39180. [PMID: 35704377 PMCID: PMC9244658 DOI: 10.2196/39180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2022] [Revised: 05/30/2022] [Accepted: 05/31/2022] [Indexed: 11/25/2022] Open
Abstract
Background Colorectal cancer (CRC) is one of the leading causes of cancer death in the United States. The incidence and prevalence of CRC have historically increased with age. Although rates of CRC in the United States have been decreasing over the past decades among those aged ≥65 years, there has been an uptick among those in younger age brackets. Google News is one of the biggest traffic drivers to top news sites. It aggregates and shares news highlights from multiple sources worldwide and organizes them by content type. Despite the widespread use of Google News, research is lacking on the type of CRC content represented in this news source. Objective The purpose of this study was to analyze content related to CRC screening and prevention in Google News articles published during National Colorectal Cancer Awareness Month (March 2022). Methods Data collection for this cross-sectional study was conducted in March 2022—National Colorectal Cancer Awareness Month. Using the term colorectal cancer, 100 English-language Google News articles were extracted and coded for content. A combined approach—deductive and inductive coding—was utilized. Descriptive analyses were conducted, and frequency distributions were reported. Univariable analyses were performed to assess differences between articles that mentioned CRC screening and those that did not via chi-square tests. Results Of the 100 articles reviewed, nearly half (n=49, 49%) were created by health news organizations, and another 27% (n=27) were created by television news services. The predominant themes in the content included age at the onset of disease (n=59, 59%), mortality related to CRC (n=57, 57%), and the severity of disease (n=50, 50%). Only 18% (n=18) of articles discussed CRC disparities, 23% (n=23) mentioned that there are hereditary forms of the disease, 36% (n=36) spoke of colonoscopy to screen for the disease, and 37% (n=37) mentioned how the disease is treated. Although most articles mentioned CRC screening (n=61, 61%), it was striking that sex was only mentioned in 34% (21/61) of these articles, colonoscopy was mentioned in 46% (28/61), and diet was mentioned in 30% (18/61). Conclusions Heightening the public’s awareness of this disease is important, but it is critical that messages related to how preventable this cancer is, who is the most likely to develop CRC, and what can be done to detect it in the early stages when the disease is the most curable be the critical elements of dialogue, particularly during National Colorectal Cancer Awareness Month. There is a need to disseminate information about early-onset CRC and the importance of screening, especially among populations with low rates of uptake. Web-based news is potentially an underutilized communication mechanism for promoting CRC screenings as secondary prevention measures for high-risk groups.
Collapse
Affiliation(s)
- Corey H Basch
- Department of Public Health, William Paterson University, Wayne, NJ, United States
| | - Grace C Hillyer
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States
| | - Erin T Jacques
- Department of Health & Human Performance, York College, City University of New York, Queens, NY, United States
| |
Collapse
|
9
|
Basch CH, Basch CE, Hillyer GC, Meleo-Erwin ZC. Social Media, Public Health, and Community Mitigation of COVID-19: Challenges, Risks, and Benefits. J Med Internet Res 2022; 24:e36804. [PMID: 35380539 PMCID: PMC9007231 DOI: 10.2196/36804] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2022] [Revised: 03/25/2022] [Accepted: 03/31/2022] [Indexed: 12/15/2022] Open
Abstract
Shortly after the first case reports in 2019, COVID-19 was declared a pandemic. Early messages from trusted experts, which later proved to be inadequate or incorrect, highlight the need for continual adjustment of messages to the public as scientific knowledge evolves. During this time, social media exploded with greatly sought-after information, some of which was misinformation based on incomplete or incorrect facts or disinformation purposefully spread to advance a specific agenda. Because of the nature of social media, information, whether accurate or not at the time posted, lives on and remains accessible to the public even when its usefulness has been discredited. While the impact of mis/disinformation on COVID-19 risk-reducing behaviors is debatable, it is clear that social media has played a significant role in both extending the reach of COVID-19-related falsehoods and promoting evidence-based content. Over the last decade, social media has become a dominant source of information that consumers turn to for health information. A great deal of misinformation and disinformation has reached large numbers of social media users, which points to a need for the agencies of the US Public Health Service to create communications to convey accurate and current information and appeals that will actually be viewed. This viewpoint highlights the challenges, risks, and potential benefits that social media present in mitigating the COVID-19 pandemic.
Collapse
Affiliation(s)
- Corey H Basch
- Department of Public Health, William Paterson University, Wayne, NJ, United States
| | - Charles E Basch
- Department of Health and Behavior Studies, Teachers College, Columbia University, New York, NY, United States
| | - Grace C Hillyer
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States
| | | |
Collapse
|
10
|
Hillyer GC, Nazareth M, Lima S, Schmitt KM, Reyes A, Fleck E, Schwartz GK, Terry MB. E-cigarette Use Among Young Adult Patients: The Opportunity to Intervene on Risky Lifestyle Behaviors to Reduce Cancer Risk. J Community Health 2022; 47:94-100. [PMID: 34453225 PMCID: PMC10034475 DOI: 10.1007/s10900-021-01027-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/19/2021] [Indexed: 10/20/2022]
Abstract
Use of e-cigarettes and other electronic nicotine delivery systems (ENDS) is on the rise. We administered a health needs survey via email to 804 adult primary care and oncology patients at a large urban academic medical center in 2019. We examined differences in e-cigarette use by smoking status, personal history of cancer, alcohol use, and second-hand tobacco smoke exposure. Of the 804 participants, 90 (11.2%) reported ever using e-cigarettes. E-cigarette use was more prevalent in young adults (risk ratio [RR] for 18-24 years: 4.58, 95% confidence interval [95% CI] 2.05, 10.26), current smoking (RR 4.64, 95% CI 1.94, 11.07), very often/often binge drinking (RR 3.04, 96% CI 1.38, 6.73), and ≥ 1 smokers in the home (RR 3.90, 95% CI 2.10, 7.23). Binge alcohol consumption and tobacco smoking are associated with increased risk cancer. Inquiries about e-cigarette use among adults 25-40 years present providers the opportunity to also counsel young adult about reducing cancer risk.
Collapse
Affiliation(s)
- Grace C Hillyer
- Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 W. 168th Street, Room 1611, New York, NY, 10032, USA.
- Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, 10032, USA.
| | - Meaghan Nazareth
- Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, 10032, USA
| | - Sarah Lima
- Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 W. 168th Street, Room 1611, New York, NY, 10032, USA
| | - Karen M Schmitt
- Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, 10032, USA
- Division of Community and Population Health, New York Presbyterian Hospital, New York, NY, 10032, USA
| | - Andria Reyes
- Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, 10032, USA
| | - Elaine Fleck
- Division of Community and Population Health, New York Presbyterian Hospital, New York, NY, 10032, USA
| | - Gary K Schwartz
- Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, 10032, USA
- Department of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY, 10032, USA
| | - Mary Beth Terry
- Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 W. 168th Street, Room 1611, New York, NY, 10032, USA
- Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, 10032, USA
| |
Collapse
|
11
|
Laforet PE, Yalamanchili B, Hillyer GC, Basch CH. YouTube as an information source on BRCA mutations: implications for patients and professionals. J Community Genet 2022; 13:257-262. [PMID: 35023041 DOI: 10.1007/s12687-022-00576-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2021] [Accepted: 01/05/2022] [Indexed: 10/19/2022] Open
Abstract
Genetic testing for BRCA1/2 mutations in early breast cancer has been shown to be beneficial, and an increase in surveillance using these genetic markers is recommended. Given this recommendation, it is likely that individuals gather information about such testing. Social media is increasingly becoming a common source of health information. One such platform known for sharing health information is YouTube. The purpose of this study was to describe content related to BRCA1/2 mutations on YouTube. The sample included 100 English language videos, which were coded for content related to BRCA1/2 mutations. The 100 videos evaluated in this study were viewed 5.5 million times. In general, the BRCA1 and BRCA2 gene mutations were mentioned simultaneously, with only 15% of videos explaining the difference in prevalence or implication of the variants individually. A great number of videos (85.0%) discussed having genetic testing to determine the presence of BRCA mutations, but only 16.0% discussed the potential harms of BRCA mutation testing and 42.0% mentioned seeking genetic counseling to determine the need for testing and interpretation of the test results. Comparing the characteristics and content of videos created by healthcare professionals (n = 71) to those created by consumers and the media (n = 29), we found that consumer/media videos were viewed twice as many times as professional videos (3,704,351 vs. 1,851,825, p = 0.04). Videos from medical professionals should include consistent information on the recommendations for individuals who test positive for a BRCA mutation. Such content should include education about BRCA mutations, testing, implications of those results and ways to reduce risk, and recommendations for increased surveillance and enhanced screening for individuals positive for BRCA mutations.
Collapse
Affiliation(s)
- Priscila E Laforet
- Department of Epidemiology, Mailman School of Public Health, Columbia University NY, New York, NY, 10032, USA
| | - Bhavya Yalamanchili
- Department of Public Health, William Paterson University, University Hall, Wayne, NJ, 07470, USA
| | - Grace C Hillyer
- Department of Epidemiology, Mailman School of Public Health, Columbia University NY, New York, NY, 10032, USA
| | - Corey H Basch
- Department of Public Health, William Paterson University, University Hall, Wayne, NJ, 07470, USA.
| |
Collapse
|
12
|
Praiss AM, Huang Y, St Clair CM, Melamed A, Khoury-Collado F, Hou JY, Gockley A, Hillyer GC, Hershman DL, Wright JD. Long-term outcomes of vaginal hysterectomy for endometrial cancer. Gynecol Oncol 2021; 164:105-112. [PMID: 34763940 DOI: 10.1016/j.ygyno.2021.10.082] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2021] [Revised: 10/14/2021] [Accepted: 10/15/2021] [Indexed: 11/17/2022]
Abstract
BACKGROUND Total vaginal hysterectomy (TVH) has been proposed as an alternative to laparoscopic (TLH) and abdominal hysterectomy (TAH), particularly for women with medical comorbidities. We examined the use and long-term outcomes of vaginal hysterectomy for women with early-stage endometrial cancer. METHODS The Surveillance, Epidemiology, and End Results-Medicare database was used to identify women with stage I-II endometrial cancer treated with primary hysterectomy from 2000 to 2015. Multivariable regression models were developed to examine clinical, demographic, and pathologic factors associated with performance of TVH. The association between route of hysterectomy and cancer-specific and overall survival was examined using multivariable Cox proportional hazards models. RESULTS A total of 19,212 patients including 837 (4.6%) who underwent TVH were identified. Performance of TVH declined from 4.5% in 2000 to 2.2% in 2015 (P < 0.0001). Compared to patients 65-69 years of age, patients 75-79 years old (aRR = 1.46; 95% CI, 1.19-1.79) and those >80 years old (aRR = 1.60; 95% CI, 1.30-1.97) were more likely to undergo TVH. Women with high grade tumors were less likely to undergo TVH. Five-year overall and cancer specific survivals were similar for TAH, TLH, and TVH. In multivariable models, there was no association between TVH and either cancer-specific survival (HR = 0.89; 95% CI, 0.65-1.22) compared to laparoscopic hysterectomy. CONCLUSION Use of TVH for stage I and II endometrial cancer has decreased in the U.S. Chronologic age is the greatest predictor of performance of TVH. Performance of TVH does not negatively impact survival for women with early-stage endometrial cancer.
Collapse
Affiliation(s)
- Aaron M Praiss
- Columbia University Vagelos College of Physicians and Surgeons, United States of America; NewYork-Presbyterian Hospital, United States of America
| | - Yongmei Huang
- Columbia University Vagelos College of Physicians and Surgeons, United States of America
| | - Caryn M St Clair
- Columbia University Vagelos College of Physicians and Surgeons, United States of America; Herbert Irving Comprehensive Cancer Center, United States of America; NewYork-Presbyterian Hospital, United States of America
| | - Alexander Melamed
- Columbia University Vagelos College of Physicians and Surgeons, United States of America; Herbert Irving Comprehensive Cancer Center, United States of America; NewYork-Presbyterian Hospital, United States of America
| | - Fady Khoury-Collado
- Columbia University Vagelos College of Physicians and Surgeons, United States of America; Herbert Irving Comprehensive Cancer Center, United States of America; NewYork-Presbyterian Hospital, United States of America
| | - June Y Hou
- Columbia University Vagelos College of Physicians and Surgeons, United States of America; Herbert Irving Comprehensive Cancer Center, United States of America; NewYork-Presbyterian Hospital, United States of America
| | - Allison Gockley
- Columbia University Vagelos College of Physicians and Surgeons, United States of America; Herbert Irving Comprehensive Cancer Center, United States of America; NewYork-Presbyterian Hospital, United States of America
| | - Grace C Hillyer
- Joseph L. Mailman School of Public Health, Columbia University, United States of America; Herbert Irving Comprehensive Cancer Center, United States of America
| | - Dawn L Hershman
- Columbia University Vagelos College of Physicians and Surgeons, United States of America; Joseph L. Mailman School of Public Health, Columbia University, United States of America; Herbert Irving Comprehensive Cancer Center, United States of America; NewYork-Presbyterian Hospital, United States of America
| | - Jason D Wright
- Columbia University Vagelos College of Physicians and Surgeons, United States of America; Herbert Irving Comprehensive Cancer Center, United States of America; NewYork-Presbyterian Hospital, United States of America.
| |
Collapse
|
13
|
Wright JD, Huang Y, Melamed A, Albright BB, Hillyer GC, Previs R, Hershman MSDL. Use and outcomes of neoadjuvant chemotherapy for metastatic uterine cancer. Gynecol Oncol 2021; 162:599-605. [PMID: 34158181 DOI: 10.1016/j.ygyno.2021.06.016] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2021] [Accepted: 06/13/2021] [Indexed: 10/21/2022]
Abstract
OBJECTIVE Neoadjuvant chemotherapy (NACT) has emerged as an alternative to primary cytoreductive surgery (PCS) for stage IV uterine cancer. We examined utilization, perioperative outcomes and survival for NACT and PCS for stage IV uterine cancer. METHODS The Surveillance, Epidemiology, End Results-Medicare database was used to identify women with stage IV uterine cancer treated from 2000 to 2015. Women were classified as NACT or PCS. Interval cytoreductive surgery (after NACT) or chemotherapy (after PCS) were recorded. The extent of surgery and perioperative outcomes were estimated for the groups. Multivariable proportional hazards models and Kaplan-Meier analyses were used to examine survival. RESULTS Among 3037 women, 1629 (53.6%) were treated with primary cytoreductive surgery, 554 (18.2%) with NACT, and 854 (28.1%) received no treatment. Use of NACT increased from 9.5% to 29.2%. After NACT, interval hysterectomy was performed in 159 (28.6%), while within the PCS group, 1052 (64.6%) received chemotherapy. Extended cytoreductive procedures were performed in 71.7% of women who received NACT vs. 79.1% after PCS (P = 0.03). The complication rate was 52.8% for NACT versus 56.2% for PCS (P = 0.42); medical complications were more frequently seen in the PCS group (39.4% versus 28.9%; P = 0.01). There was no difference in cancer specific (P = 0.48) or overall survival (P = 0.25) in women who received both chemotherapy and surgery regardless of whether the initial treatment was NACT or PCS. CONCLUSION Use of NACT is increasing for advanced stage uterine cancer. There was no difference in survival between NACT and primary cytoreductive surgery and NACT was associated with fewer perioperative medical complications.
Collapse
Affiliation(s)
- Jason D Wright
- Columbia University Vagelos College of Physicians and Surgeons, USA; Herbert Irving Comprehensive Cancer Center, USA; NewYork-Presbyterian Hospital, USA.
| | - Yongmei Huang
- Columbia University Vagelos College of Physicians and Surgeons, USA
| | - Alexander Melamed
- Columbia University Vagelos College of Physicians and Surgeons, USA; Herbert Irving Comprehensive Cancer Center, USA; NewYork-Presbyterian Hospital, USA
| | | | - Grace C Hillyer
- Joseph L. Mailman School of Public Health, Columbia University, USA; Herbert Irving Comprehensive Cancer Center, USA
| | | | - M S Dawn L Hershman
- Columbia University Vagelos College of Physicians and Surgeons, USA; Joseph L. Mailman School of Public Health, Columbia University, USA; Herbert Irving Comprehensive Cancer Center, USA; NewYork-Presbyterian Hospital, USA
| |
Collapse
|
14
|
Basch CE, Basch CH, Hillyer GC, Meleo-Erwin ZC, Zagnit EA. YouTube Videos and Informed Decision-Making About COVID-19 Vaccination: Successive Sampling Study. JMIR Public Health Surveill 2021; 7:e28352. [PMID: 33886487 PMCID: PMC8104074 DOI: 10.2196/28352] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2021] [Revised: 04/16/2021] [Accepted: 04/19/2021] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Social media platforms such as YouTube are used by many people to seek and share health-related information that may influence their decision-making about COVID-19 vaccination. OBJECTIVE The purpose of this study was to improve the understanding about the sources and content of widely viewed YouTube videos on COVID-19 vaccination. METHODS Using the keywords "coronavirus vaccination," we searched for relevant YouTube videos, sorted them by view count, and selected two successive samples (with replacement) of the 100 most widely viewed videos in July and December 2020, respectively. Content related to COVID-19 vaccines were coded by two observers, and inter-rater reliability was demonstrated. RESULTS The videos observed in this study were viewed over 55 million times cumulatively. The number of videos that addressed fear increased from 6 in July to 20 in December 2020, and the cumulative views correspondingly increased from 2.6% (1,449,915 views) to 16.6% (9,553,368 views). There was also a large increase in the number of videos and cumulative views with respect to concerns about vaccine effectiveness, from 6 videos with approximately 6 million views in July to 25 videos with over 12 million views in December 2020. The number of videos and total cumulative views covering adverse reactions almost tripled, from 11 videos with approximately 6.5 million (11.7% of cumulative views) in July to 31 videos with almost 15.7 million views (27.2% of cumulative views) in December 2020. CONCLUSIONS Our data show the potentially inaccurate and negative influence social media can have on population-wide vaccine uptake, which should be urgently addressed by agencies of the United States Public Health Service as well as its global counterparts.
Collapse
Affiliation(s)
- Charles E Basch
- Teachers College, Columbia University, New York, NY, United States
| | - Corey H Basch
- William Paterson University, Wayne, NJ, United States
| | - Grace C Hillyer
- Mailman School of Public Health, Columbia University, New York, NY, United States
| | | | - Emily A Zagnit
- Milken Institute School of Public Health, George Washington University, Washington, DC, United States
| |
Collapse
|
15
|
Seidel EJ, Hillyer GC, Basch CH. Anxiety and COVID-19: A study of online content readability. J Prev Interv Community 2021; 49:193-201. [PMID: 33871313 DOI: 10.1080/10852352.2021.1908874] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
The uncertain and unprecedented nature of the COVID-19 pandemic is anxiety-provoking and some people are seeking information about this anxiety online. The purpose of this study was to assess the readability levels of online articles related to anxiety and COVID-19. The first 50 English language URLs to appear in a Google search in July 2020 were assessed for readability using Readable.io. A five-measure panel consisting of the Flesch-Kincaid Grade Level (FKGL), Gunning Fog Index, Coleman-Liau Index (CLI), the Simple Measure of Gobbledygook (SMOG) Grade Level, and Flesch-Kincaid Reading Ease (FRE) was used, and grade level scores were recoded as easy, average, and difficult readability. Websites were grouped as commercial vs. noncommercial sources bases on the URL. Of the 50 articles evaluated, the majority were found to be written at a difficult (>10th grade) reading level with four of the five measures employed which is well above the 7-8th grade reading level abilities of most Americans. Given the importance of access to mental health information during the pandemic, it is crucial that the resources available to the general public are written at a reading level that is comprehensible to ensure they are understood.
Collapse
Affiliation(s)
- Erica J Seidel
- Department of Student Life/Counseling Center, City University of New York-Borough of Manhattan Community College, New York, New York, USA
| | - Grace C Hillyer
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA
| | - Corey H Basch
- Department of Public Health, William Paterson University, Wayne, New Jersey, USA
| |
Collapse
|
16
|
Poon BY, Kroenke CH, Hillyer GC, Lamerato LE, Stewart AL, Neugut AI, Hershman DL, Kushi LH. Patient Experience of Interpersonal Processes of Care and Subsequent Utilization of Hormone Therapy for Non-Metastatic Breast Cancer. Cancer Epidemiol Biomarkers Prev 2021. [DOI: 10.1158/1055-9965.epi-21-0214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Abstract
Purpose: We examined the association between patient experience of care and utilization of hormone therapy (HT) in the treatment of non-metastatic hormone-receptor positive (HR+) breast cancer. Methods: Patients newly diagnosed with non-metastatic breast cancer were recruited from 2006 to 2010 for a longitudinal multisite cohort study in New York, NY, Detroit, MI, and Northern California. Of 1,145 patients surveyed, 797 had HR+ tumors eligible for HT and all necessary data. We assessed patient experience 4 to 8 weeks after recruitment using 6 subscales of the Interpersonal Processes of Care (IPC) survey: compassion, discrimination, and hurriedness in communication, as well as concern elicitation, result explanation, and patient-centered decision-making. Subscales ranged from 1 to 5 where higher values indicated better experiences. HT for 5 years is standard care for HR+ breast cancer so utilization was defined as time from diagnosis to HT initiation and time from HT initiation to early discontinuation before 5 years as calculated from follow-up survey responses. We evaluated the relationship between patient experience and utilization using Cox proportional hazard models, controlling for education, income, insurance, marital status, social support, site of care, age at diagnosis, stage, grade, tumor size, Charlson comorbidity index, and chemotherapy. Results: Median age at diagnosis was 59 years (interquartile range 51–66) with the majority diagnosed at clinical stage 1 (54%) and with low or moderate grade disease (78%). Less hurried communication was associated with increased probability of HT initiation (Hazards Ratio (HR) 1.15; 95% Confidence Interval (CI) 1.03, 1.30; p = 0.018). Conversely, more patient-centered decision-making was associated with increased probability of early discontinuation (HR 1.29; CI, 1.03, 1.63; p = 0.028). All other associations were null. Conclusion: While unhurried communication was associated with initiation of hormone therapy, patient-centered decision-making was associated with early discontinuation. Different aspects of patient experience may have vastly different relationships with patient utilization of health services. Actionable assessments of patient experience may require measurement along multiple dimensions.
Collapse
|
17
|
Basch CH, Laforet PE, Hillyer GC, Seidel EJ, Jaime C. Content in YouTube Videos for Rosacea: Cross-sectional Study. JMIR Dermatol 2021; 4:e24517. [PMID: 37632798 PMCID: PMC10501524 DOI: 10.2196/24517] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2020] [Revised: 10/31/2020] [Accepted: 01/15/2021] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Rosacea is an inflammatory skin disease that is chronic in nature. In addition to the physical symptoms, there are substantial quality of life issues that patients with rosacea experience, largely due to the visible nature in which rosacea manifests. OBJECTIVE The purpose of this study was to describe the content related to rosacea in highly viewed English- and Spanish-language videos on YouTube. METHODS We coded identifying information for each video and categories including characteristics of rosacea, clinical solutions, and alternative solutions. The 100 YouTube videos examined were viewed 18.5 million times between 2006 and 2020, and 57.3% (10,652,665/18,592,742) of these views were of consumer videos. RESULTS Videos posted by consumers more often promoted or were trying to sell a product or procedure (32/55, 58% of consumers vs 10/31, 32% of medical professionals and 4/14, 29% of television, internet, news, or entertainment sources; P=.03) and more frequently mentioned the use of makeup or other ways to cover up rosacea (30/55, 55% of consumers vs 6/31, 19% of medical professionals and 2/14, 14% of television, internet, news, or entertainment sources; P<.001). Videos sourced from medical professionals more often mentioned medication (17/31, 55%) than videos uploaded by consumers (14/55, 25%) or TV, internet, news, or entertainment sources (3/14, 21%) (P=.01). CONCLUSIONS Given that rosacea is experienced differently for each person, consumer advice that works for one individual may not work for another. There is a need for reliable videos on rosacea to emphasize this and clarify misconceptions.
Collapse
Affiliation(s)
- Corey H Basch
- Department of Public Health, William Paterson University, Wayne, NJ, United States
| | - Priscila E Laforet
- Division of Hematology/Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, United States
| | - Grace C Hillyer
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States
| | - Erica J Seidel
- Department of Student Life/Counseling Center, Borough of Manhattan Community College, New York, NY, United States
| | - Christie Jaime
- Department of Public Health, William Paterson University, Wayne, NJ, United States
| |
Collapse
|
18
|
Basch CH, Hillyer GC, Wahrman MZ, Garcia P, Basch CE. DNA testing information on YouTube: Inadequate advice can mislead and harm the public. J Genet Couns 2020; 30:785-792. [PMID: 33382174 DOI: 10.1002/jgc4.1375] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2020] [Revised: 11/29/2020] [Accepted: 11/30/2020] [Indexed: 01/07/2023]
Abstract
Direct-to-consumer (DTC) DNA (i.e., genetic) testing has become very popular, with close to 30 million Americans having used these services. The 100 most widely viewed DNA YouTube testing videos were analyzed to determine whether they are providing adequate information for consumers. The top 100 videos had more than 300 million cumulative views, showing the popularity and reach of the information source. While many videos addressed the specimen collection process, family roots and ancestry, and the prospect of uncovering unexpected information about family or health leading to possible distress, almost none of the videos addressed accuracy or confidentiality issues, which are major issues of DNA testing. It is recommended that further information on those issues be made readily available, and more vigilant oversight by regulatory agencies be implemented. Such oversight should include monitoring what information is and is not readily provided by each company, and the veracity of information being communicated to existing and prospective consumers. We also recommend that for medical issues, clinical genetic testing, along with genetic counseling by genetic counselors, be the method of choice.
Collapse
Affiliation(s)
- Corey H Basch
- Department of Public Health, William Paterson University, Wayne, NJ, USA
| | - Grace C Hillyer
- Department of Epidemiology, Mailman School of Public Health, Columbia University NY, New York, NY, USA
| | - Miryam Z Wahrman
- Department of Biology, William Paterson University, Wayne, NJ, USA
| | - Philip Garcia
- Department of Public Health, William Paterson University, Wayne, NJ, USA
| | - Charles E Basch
- Health and Behavior Studies, Teachers College, Columbia University NY, New York, NY, USA
| |
Collapse
|
19
|
Liang MI, Chen L, Hershman DL, Hillyer GC, Huh WK, Guyton A, Wright JD. Total and out-of-pocket costs for PARP inhibitors among insured ovarian cancer patients. Gynecol Oncol 2020; 160:793-799. [PMID: 33375989 DOI: 10.1016/j.ygyno.2020.12.015] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2020] [Accepted: 12/15/2020] [Indexed: 12/22/2022]
Abstract
OBJECTIVE To evaluate total and out-of-pocket costs for poly(ADP-ribose) polymerase (PARP) inhibitors and differences based on insurance characteristics. METHODS We identified ovarian cancer patients who were prescribed niraparib, olaparib, or rucaparib from the MarketScan (2014-2017) and Surveillance, Epidemiology, and End Results (SEER)-Medicare (2014-2016) databases. Drug costs were estimated for a 30-day supply. Descriptive statistics and Wilcoxon rank sum tests were performed. RESULTS 590 commercially insured beneficiaries from MarketScan and 213 SEER-Medicare beneficiaries were prescribed PARP inhibitors for a median 112 days. For commercially insured beneficiaries, median total cost was $13,342 (IQR $12,022-$14,256). Median out-of-pocket cost was $44 (IQR $0-$120) and PARP inhibitors accounted for a median 90.8% of patients' total out-of-pocket drug spending. High-deductible health plan was not associated with higher out-of-pocket costs (N = 570; median $0 vs. $45, P = 0.87). For SEER-Medicare beneficiaries, median total cost was $12,798 (IQR $11,704-$13,180). Median out-of-pocket cost was $370 (IQR $2-$1234) and PARP inhibitors accounted for a median 99.0% of patients' total out-of-pocket drug spending. Out-of-pocket costs were lower for dual-eligible patients with supplemental Medicaid prescription coverage (N = 209; median $1 vs. $911, P < 0.001). CONCLUSIONS Although insurers are responsible for a large proportion of PARP inhibitor costs, out-of-pocket costs for PARP inhibitors account for a majority of patients' drug spending. SEER-Medicare beneficiaries had higher out-of-pocket costs than patients with commercial insurance, which was offset for those with supplemental Medicaid prescription coverage.
Collapse
Affiliation(s)
- Margaret I Liang
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States of America.
| | - Ling Chen
- Columbia University Vagelos College of Physicians and Surgeons, United States of America
| | - Dawn L Hershman
- Columbia University Vagelos College of Physicians and Surgeons, United States of America; Mailman School of Public Health, Columbia University, United States of America; Herbert Irving Comprehensive Cancer Center of Columbia University, United States of America
| | - Grace C Hillyer
- Mailman School of Public Health, Columbia University, United States of America; Herbert Irving Comprehensive Cancer Center of Columbia University, United States of America
| | - Warner K Huh
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States of America
| | - Allison Guyton
- Department of Pharmacy, University of Alabama at Birmingham, Birmingham, AL, United States of America
| | - Jason D Wright
- Columbia University Vagelos College of Physicians and Surgeons, United States of America; Herbert Irving Comprehensive Cancer Center of Columbia University, United States of America
| |
Collapse
|
20
|
Chen LC, Huang Y, Hou JY, Khoury-Collado F, Melamed A, St Clair CM, Tergas AI, Hur C, Hillyer GC, Hershman DL, Wright JD. Toxicity after adjuvant therapy for stage III uterine cancer. Gynecol Oncol 2020; 159:737-743. [PMID: 33008633 DOI: 10.1016/j.ygyno.2020.09.033] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2020] [Accepted: 09/15/2020] [Indexed: 11/26/2022]
Abstract
OBJECTIVE The optimal adjuvant therapy for stage III endometrial cancer is unknown. Studies have suggested that combination therapy with chemotherapy and radiation is associated with improved survival. We examined early and late-term toxicities associated with chemotherapy (CT), external beam radiotherapy (RT), or combination chemoradiotherapy for stage III uterine cancer. METHODS The SEER-Medicare database was used to identify women age ≥ 65 years with stage III uterine cancer who received adjuvant CT, RT, or chemoradiotherapy from 2000 to 2015. The associations between therapy and early and late-term toxicities identified with billing claims, hospitalizations and emergency department visits were examined using multivariable regression models. RESULTS A total of 2185 patients were identified including 574 (26.3%) who received CT, 636 (29.1%) who received RT, and 975 (44.6%) who received chemoradiotherapy. The proportion of patients receiving chemoradiotherapy or CT increased over time. During the first 6 and 12 months of adjuvant therapy, RT was associated with a lower risk of early-term toxicity compared to chemoradiotherapy (aRR = 0.59, 95%CI 0.49-0.70 and aRR = 0.76, 95%CI 0.67-0.86, respectively) while CT shared a similar risk of early toxicities as chemoradiotherapy. CT and RT shared a similar risk of late-term toxicities compared to chemoradiotherapy. CT and RT alone were associated with a higher hazard for overall mortality than chemoradiotherapy (aHR = 1.27, 95% CI 1.10-1.47 and aHR = 1.25, 95% CI 1.08-1.44, respectively). CONCLUSION Chemoradiotherapy is associated with lower mortality compared to single modality therapy and has a similar risk of early and late term toxicities compared to CT, though higher risk of early toxicities compared to RT.
Collapse
Affiliation(s)
- Lillian C Chen
- Columbia University Vagelos College of Physicians and Surgeons, USA
| | - Yongmei Huang
- Columbia University Vagelos College of Physicians and Surgeons, USA
| | - June Y Hou
- Columbia University Vagelos College of Physicians and Surgeons, USA; Herbert Irving Comprehensive Cancer Center, USA; NewYork-Presbyterian Hospital, USA
| | - Fady Khoury-Collado
- Columbia University Vagelos College of Physicians and Surgeons, USA; Herbert Irving Comprehensive Cancer Center, USA; NewYork-Presbyterian Hospital, USA
| | - Alexander Melamed
- Columbia University Vagelos College of Physicians and Surgeons, USA; Herbert Irving Comprehensive Cancer Center, USA; NewYork-Presbyterian Hospital, USA
| | - Caryn M St Clair
- Columbia University Vagelos College of Physicians and Surgeons, USA; Herbert Irving Comprehensive Cancer Center, USA; NewYork-Presbyterian Hospital, USA
| | - Ana I Tergas
- Columbia University Vagelos College of Physicians and Surgeons, USA; Joseph L. Mailman School of Public Health, Columbia University, USA; Herbert Irving Comprehensive Cancer Center, USA; NewYork-Presbyterian Hospital, USA
| | - Chin Hur
- Columbia University Vagelos College of Physicians and Surgeons, USA; Joseph L. Mailman School of Public Health, Columbia University, USA; Herbert Irving Comprehensive Cancer Center, USA; NewYork-Presbyterian Hospital, USA
| | - Grace C Hillyer
- Joseph L. Mailman School of Public Health, Columbia University, USA; Herbert Irving Comprehensive Cancer Center, USA
| | - Dawn L Hershman
- Columbia University Vagelos College of Physicians and Surgeons, USA; Joseph L. Mailman School of Public Health, Columbia University, USA; Herbert Irving Comprehensive Cancer Center, USA; NewYork-Presbyterian Hospital, USA
| | - Jason D Wright
- Columbia University Vagelos College of Physicians and Surgeons, USA; Herbert Irving Comprehensive Cancer Center, USA; NewYork-Presbyterian Hospital, USA.
| |
Collapse
|
21
|
Duran-Becerra B, Hillyer GC, Cosgrove A, Basch CH. Climate change on YouTube: A potential platform for youth learning. Health Promot Perspect 2020; 10:282-286. [PMID: 32802765 PMCID: PMC7420161 DOI: 10.34172/hpp.2020.42] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2020] [Accepted: 05/15/2020] [Indexed: 11/22/2022] Open
Abstract
Background: Climate change is one of the most critical threats to our society. The purpose of this cross-sectional study was to describe the content of the most viewed climate change videos on YouTube. Methods: The term "climate change" was used to search on YouTube to garner a sample of the 100most widely-viewed videos. Videos in a language other than English, or considered irrelevant, were excluded. Using a fact sheet from National Aeronautics and Space Administration, content categories were created and successively coded. Results: The mean number of views for the 100 videos evaluated was 231,140.2 views (SD=718, 399.5) and the mean length was 12.1 minutes (SD= 24.1). Most videos were uploaded by a news source (77.0%), included a belief that climate change is happening (77.0%), and mentioned the impact of climate change on the environment (71.0%). Only one-third of the videos mentioned how to prevent climate change (33.0%). More than half focused on a specific environment and, of those, 47.2% specifically focused on cities. Compared to videos that did not focus on a specific environment, the videos with an environmental focus were more often intended for adults (87.3% vs. 53.3%, P≤0.001). Conclusion: This study highlights the need for climate change YouTube videos intended for youth. Targeting youth may lead to engagement of younger generations in climate change discourse and inspire climate action. Further research is needed to determine the effectiveness of YouTube as a platform for educational videos on climate change.
Collapse
Affiliation(s)
| | - Grace C Hillyer
- Herbert Irving Comprehensive Cancer Center, Columbia University, NY, NY 10032, USA.,Department of Epidemiology, Mailman School of Public Health, Columbia University NY, NY 10032, USA
| | - Alison Cosgrove
- Department of Public Health, William Paterson University, Wayne, NJ 07470, USA
| | - Corey H Basch
- Department of Public Health, William Paterson University, Wayne, NJ 07470, USA
| |
Collapse
|
22
|
Basch CH, Hillyer GC, Jaime C. COVID-19 on TikTok: harnessing an emerging social media platform to convey important public health messages. Int J Adolesc Med Health 2020; 34:367-369. [PMID: 32776899 DOI: 10.1515/ijamh-2020-0111] [Citation(s) in RCA: 51] [Impact Index Per Article: 12.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2020] [Accepted: 06/21/2020] [Indexed: 11/15/2022]
Abstract
OBJECTIVES TikTok is a popular social media platform, especially among those who are 13-24 years of age. The purpose of this cross-sectional study was to describe the content of COVID-19 material on TikTok. METHODS A total of 100 videos posted under the hashtag #Coronavirus were included in this study along with all (n=17) posts uploaded by the World Health Organization (WHO). RESULTS Overall, these videos were viewed 1,194,081,700 times. The most commonly cited topics included anxiety (14.5%) with more than 190.6 million views and quarantine (10.3%) with 106.6 million views. Fewer than 10% of videos mentioned how the virus is transmitted, symptoms, and prevention. WHO videos more often focused on viral transmission and symptoms but covered these topics in fewer than 10% of the videos. CONCLUSIONS Although research suggests that cases of COVID-19 may be less severe in those under 18 years of age, social distancing remains paramount due to the possibility of transmission even in those with minimal or no symptoms. For young adults in particular, the WHO suggests staying connected through social media and making every attempt to stay positive. TikTok has the potential, not only to convey important health information, but to address these aspects of the COVID-19 pandemic as well.
Collapse
Affiliation(s)
- Corey H Basch
- Department of Public Health, William Paterson University, Wayne, NJ, USA
| | - Grace C Hillyer
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
| | - Christie Jaime
- Department of Public Health, William Paterson University, Wayne, NJ, USA
| |
Collapse
|
23
|
Accordino MK, Wright JD, Buono D, Lin A, Huang Y, Neugut AI, Hillyer GC, Hershman DL. Incidence and Predictors of Diabetes Mellitus after a Diagnosis of Early-Stage Breast Cancer in the Elderly Using Real-World Data. Breast Cancer Res Treat 2020; 183:201-211. [PMID: 32591988 PMCID: PMC8403515 DOI: 10.1007/s10549-020-05756-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2020] [Accepted: 06/16/2020] [Indexed: 12/11/2022]
Abstract
PURPOSE The incidence and predictors of diabetes (DM) in patients with breast cancer (BC) were evaluated. We compared DM incidence and physician access in BC patients to matched controls. METHODS We identified women with stage I-III BC diagnosed from 2005 to 2013 in the SEER-Medicare database, with ≥ 2 years of follow-up after diagnosis, without previous DM claims. Incident DM was determined by ≥ 1 DM claims after BC diagnosis. Multivariable analysis was used to identify factors associated with incident DM. Age- and race-matched non-cancer controls were obtained from a 5% random sample and assigned an index date. Physician and PCP visits per-patient-per-year were compared between cases and controls in the two-year period prior to and after the index date. RESULTS Among 14,506 eligible BC patients, 3234 (22.3%) developed DM versus 16.5% of controls. Among BC patients, factors associated with incident DM included race (Black OR 1.63 95% CI 1.39-1.93, Hispanic OR 3.03 95% CI 1.92-4.81; vs. Caucasians), SES (Quintile 0 vs. Quintile 4 OR 1.55 95% CI 1.33-1.78), and receipt of chemotherapy (vs. none OR 1.19 95% CI 1.08-1.31). Among cases and controls, respectively, median physician visits per-patient-per-year were 19 and 17 prior to the index date, and 46 and 19 after the index date; median PCP visits were 2 for both groups in both periods. CONCLUSION About 22% of BC patients developed DM, more than controls in the same period. While there were differences in healthcare access, there weren't differences in PCP access between groups. This represents an opportunity for better comorbidity management in BC patients.
Collapse
Affiliation(s)
- Melissa K Accordino
- Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA.
- Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY, USA.
| | - Jason D Wright
- Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY, USA
- Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA
| | - Donna Buono
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA
| | - Aijing Lin
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA
| | - Yongmei Huang
- Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA
| | - Alfred I Neugut
- Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
- Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY, USA
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA
| | - Grace C Hillyer
- Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY, USA
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA
| | - Dawn L Hershman
- Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
- Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY, USA
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA
| |
Collapse
|
24
|
Abstract
This study examined 100 widely viewed YouTube videos on COVID-19 vaccination. Information such as length, format, upload source, content, and cumulative views was coded. As of April 6, 2020, the videos were viewed >33 million times. Almost 75% were uploaded by news sources (garnering >20 million views). While only 16% were uploaded by consumers, these videos garnered over 25% of cumulative views (n = 8,581,186 views). The majority of videos mentioned the vaccine manufacturing process (61.0%) and 45.0% speculated on the amount of time needed to have a vaccine ready for use, which most often was thought to be 1-2 years. Even once the biological and technical aspects of vaccine development and manufacturing are accomplished, the benefits conferred on population health will also depend on public willingness to be vaccinated. Ongoing tracking of YouTube is needed to identify what is communicated about vaccines for COVID-19. To the extent that public health officials learn how to create videos about the safety and effectiveness of a COVID-19 vaccine, which attract viewers, this could help increase awareness and interest about vaccination and help individuals make an informed decision about vaccine uptake.
Collapse
Affiliation(s)
- Corey H Basch
- Department of Public Health, William Paterson University , Wayne, NJ, USA
| | - Grace C Hillyer
- Department of Epidemiology, Mailman School of Public Health, Columbia University , New York, NY, USA
| | - Emily A Zagnit
- Milken Institute School of Public Health, George Washington University , Washington, DC, USA
| | - Charles E Basch
- Health and Behavior Studies, Teachers College, Columbia University , New York, NY, USA
| |
Collapse
|
25
|
Leng S, Chen Y, Tsai WY, Bhutani D, Hillyer GC, Lim E, Accordino MK, Wright JD, Hershman DL, Lentzsch S, Neugut AI. Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple Myeloma. J Natl Compr Canc Netw 2020; 17:22-28. [PMID: 30659126 DOI: 10.6004/jnccn.2018.7079] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2018] [Accepted: 08/20/2018] [Indexed: 02/03/2023]
Abstract
Background: Bisphosphonates reduce skeletal-related events (SREs) in patients with multiple myeloma (MM) and, in some studies, improved survival. Since 2011, bisphosphonate use has been recommended by NCCN for all patients with newly diagnosed MM receiving antineoplastic therapy independent of the presence of bone disease. This study investigated their use after these guidelines were established. Methods: We identified patients aged ≥65 years in the SEER-Medicare database with newly diagnosed MM between January 1, 2012, and December 31, 2013, who received antineoplastic therapy, had ≥6 months of follow-up, and did not receive prior bisphosphonates. Presence of SREs at diagnosis was identified, including pathologic fracture, spinal cord compression, radiation to bone, or surgery to bone. Use of bisphosphonates was defined as having ≥1 claim for an intravenous or oral bisphosphonate within 6 months after the start of antineoplastic therapy. We used multivariable modeling to compare users with nonusers, controlling for demographic and clinical covariates. We compared overall survival between users and nonusers using proportional hazards analysis. Results: Of 1,309 patients identified, 720 (55%) used a bisphosphonate. Factors associated with use included SRE at diagnosis (adjusted odds ratio [AOR], 2.60; 95% CI, 1.98-3.40), hypercalcemia (AOR, 1.74; 95% CI, 1.26-2.41), and use of proteasome inhibitor + immunomodulatory imide therapy (AOR, 1.70; 95% CI, 1.21-2.39). Chronic kidney disease (AOR, 0.48; 95% CI, 0.35-0.66) was associated with decreased use. Bisphosphonate use was associated with reduced mortality (hazard ratio, 0.70; 95% CI, 0.56-0.88). Conclusions: Although bisphosphonate use is recommended for all patients with newly diagnosed MM receiving antineoplastic therapy, 45% of patients in the United States did not receive this guideline-recommended care.
Collapse
|
26
|
Hillyer GC, Mapanga W, Jacobson JS, Graham A, Mmoledi K, Makhutle R, Osei-Fofie D, Mulowayi M, Masuabi B, Bulman WA, Neugut AI, Joffe M. Attitudes toward tobacco cessation and lung cancer screening in two South African communities. Glob Public Health 2020; 15:1537-1550. [PMID: 32406331 DOI: 10.1080/17441692.2020.1761425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Among men in South Africa, the prevalence of tobacco smoking is as high as 33%. Although smoking is responsible for most lung cancer in South Africa, occupational and environmental exposures contribute greatly to risk. We conducted a tobacco and lung cancer screening needs assessment and administered surveys to adults who smoked >100 cigarettes in their lifetime in Johannesburg (urban) and Kimberley (rural). We compared tobacco use, risk exposure, attitudes toward and knowledge of, and receptivity to cessation and screening, by site. Of 324 smokers, nearly 85% of current smokers had a <30 pack-year history of smoking; 58.7% had tried to stop smoking ≥1 time, and 78.9% wanted to quit. Kimberley smokers more often reported being advised by a healthcare provider to stop smoking (56.5% vs. 37.3%, p=0.001) than smokers in Johannesburg but smokers in Johannesburg were more willing to stop smoking if advised by their doctor (72.9% vs. 41.7%, p<0.001). Findings indicate that tobacco smokers in two geographic areas of South Africa are motivated to stop smoking but receive no healthcare support to do so. Developing high risk criteria for lung cancer screening and creating tobacco cessation infrastructure may reduce tobacco use and decrease lung cancer mortality in South Africa.
Collapse
Affiliation(s)
- Grace C Hillyer
- Mailman School of Public Health, Columbia University, New York, NY, USA.,Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA
| | - Witness Mapanga
- Non-Communicable Diseases Research (NCDR) Division of the Wits Health Consortium, University of Witwatersrand, Johannesburg, South Africa
| | - Judith S Jacobson
- Mailman School of Public Health, Columbia University, New York, NY, USA.,Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA
| | - Anita Graham
- Non-Communicable Diseases Research (NCDR) Division of the Wits Health Consortium, University of Witwatersrand, Johannesburg, South Africa
| | - Keletso Mmoledi
- Non-Communicable Diseases Research (NCDR) Division of the Wits Health Consortium, University of Witwatersrand, Johannesburg, South Africa
| | - Raynolda Makhutle
- Non-Communicable Diseases Research (NCDR) Division of the Wits Health Consortium, University of Witwatersrand, Johannesburg, South Africa
| | | | | | | | - William A Bulman
- Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA
| | - Alfred I Neugut
- Mailman School of Public Health, Columbia University, New York, NY, USA.,Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.,Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA
| | - Maureen Joffe
- Non-Communicable Diseases Research (NCDR) Division of the Wits Health Consortium, University of Witwatersrand, Johannesburg, South Africa
| |
Collapse
|
27
|
Basch CH, Hillyer GC, Meleo-Erwin ZC, Jaime C, Mohlman J, Basch CE. Correction: Preventive Behaviors Conveyed on YouTube to Mitigate Transmission of COVID-19: Cross-Sectional Study. JMIR Public Health Surveill 2020; 6:e19601. [PMID: 32374718 PMCID: PMC7240432 DOI: 10.2196/19601] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2020] [Accepted: 04/27/2020] [Indexed: 11/13/2022] Open
Abstract
[This corrects the article DOI: 10.2196/18807.].
Collapse
Affiliation(s)
- Corey H Basch
- William Paterson University, Wayne, NJ, United States
| | - Grace C Hillyer
- Mailman School of Public Health, Columbia University, New York, NY, United States
| | | | | | - Jan Mohlman
- William Paterson University, Wayne, NJ, United States
| | - Charles E Basch
- Teachers College, Columbia University, New York, NY, United States
| |
Collapse
|
28
|
Basch CE, Basch CH, Hillyer GC, Jaime C. The Role of YouTube and the Entertainment Industry in Saving Lives by Educating and Mobilizing the Public to Adopt Behaviors for Community Mitigation of COVID-19: Successive Sampling Design Study. JMIR Public Health Surveill 2020; 6:e19145. [PMID: 32297593 PMCID: PMC7175786 DOI: 10.2196/19145] [Citation(s) in RCA: 37] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2020] [Accepted: 04/10/2020] [Indexed: 01/12/2023] Open
Abstract
Background Effective community mitigation through voluntary behavior change is currently the best way to reduce mortality caused by coronavirus disease (COVID-19). This study builds on our prior study based on the scientific premise that YouTube is one of the most effective ways to communicate and mobilize the public in community mitigation to reduce exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Objective Because of the rapidly changing nature of YouTube in the context of the COVID-19 pandemic, we conducted a follow-up study to document how coverage of preventive behaviors for effective community mitigation has changed. Methods A successive sampling design was used to compare coverage of behaviors to mitigate community transmission of COVID-19 in the 100 most widely viewed YouTube videos in January 2020 and March 2020. Results Videos in the January and March samples were viewed >125 million times and >355 million times, respectively. Fewer than half of the videos in either sample covered any of the prevention behaviors recommended by the US Centers for Disease Control and Prevention, but many covered key prevention behaviors and were very widely viewed. There were no videos uploaded by entertainment television in the January sample, but this source comprised the majority of videos and garnered the majority of cumulative views in the March sample. Conclusions This study demonstrates the incredible reach of YouTube and the potential value of partnership with the entertainment industry for communicating and mobilizing the public about community mitigation to reduce mortality from the COVID-19 viral pandemic.
Collapse
Affiliation(s)
- Charles E Basch
- Teachers College, Columbia University, New York, NY, United States
| | - Corey H Basch
- William Paterson University, Wayne, NJ, United States
| | - Grace C Hillyer
- Mailman School of Public Health, Columbia University, New York, NY, United States
| | | |
Collapse
|
29
|
Basch CH, Hillyer GC, Meleo-Erwin ZC, Jaime C, Mohlman J, Basch CE. Preventive Behaviors Conveyed on YouTube to Mitigate Transmission of COVID-19: Cross-Sectional Study. JMIR Public Health Surveill 2020; 6:e18807. [PMID: 32240096 PMCID: PMC7124952 DOI: 10.2196/18807] [Citation(s) in RCA: 70] [Impact Index Per Article: 17.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2020] [Revised: 03/30/2020] [Accepted: 03/31/2020] [Indexed: 12/04/2022] Open
Abstract
Background Accurate information and guidance about personal behaviors that can reduce exposure to severe acute respiratory syndrome coronavirus 2 are among the most important elements in mitigating the spread of coronavirus disease 2019 (COVID-19). With over 2 billion users, YouTube is a media channel that millions turn to when seeking information. Objective At the time of this study, there were no published studies investigating the content of YouTube videos related to COVID-19. This study aims to address this gap in the current knowledge. Methods The 100 most widely viewed YouTube videos uploaded throughout the month of January 2020 were reviewed and the content covered was described. Collectively, these videos were viewed over 125 million times. Results Fewer than one-third of the videos covered any of the seven key prevention behaviors listed on the US Centers for Disease Control and Prevention website. Conclusions These results represent an important missed opportunity for disease prevention.
Collapse
Affiliation(s)
- Corey H Basch
- William Paterson University, Wayne, NJ, United States
| | - Grace C Hillyer
- Mailman School of Public Health, Columbia University, New York, NY, United States
| | | | | | - Jan Mohlman
- William Paterson University, Wayne, NJ, United States
| | - Charles E Basch
- Teachers College, Columbia University, New York, NY, United States
| |
Collapse
|
30
|
Hillyer GC, Schmitt KM, Reyes A, Cruz A, Lizardo M, Schwartz GK, Terry MB. Community education to enhance the more equitable use of precision medicine in Northern Manhattan. J Genet Couns 2020; 29:247-258. [PMID: 32157769 DOI: 10.1002/jgc4.1244] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2019] [Revised: 02/15/2020] [Accepted: 02/17/2020] [Indexed: 12/30/2022]
Abstract
Focusing screening and treatment to those most likely to benefit is the promise of precision medicine but inequitable distribution of precision medicine innovations may exacerbate health disparities. We investigated whether complex genomic concepts can be successfully communicated to diverse populations. Incorporating principles of Community-based Participatory Research, we created a precision medicine curriculum tailored to the needs of our predominantly Hispanic community. We administered the curriculum over 26 months, assessed pre- and post-test comprehension of 8 genetics-related terms, and compared comprehension differences based on demography and health literacy. In total, 438 individuals completed pre-/post-test assessments. At pre-test, 45.6% scored ≥75% across eight major constructs; 66.7% at post-test. Comprehension increased for 7/8 terms with greatest pre/post-test increases for 'mutation' (55% to 78%) and 'sporadic' (34% to 59%). Mean pre-test comprehension scores (≥75%) were lower for Spanish versus. English speakers; mean post-test scores were equivalent. No heterogeneity by demographics or health literacy was observed. We demonstrate that a brief community educational program can improve knowledge of complex genomic concepts. Interventions to increase understanding of genomic concepts underlying precision medicine are key to patients making informed treatment and prevention decisions and may lead to more equitable uptake of precision medicine initiatives.
Collapse
Affiliation(s)
- Grace C Hillyer
- Department of Epidemiology, Mailman School of Public Health, New York, NY, USA.,Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA
| | - Karen M Schmitt
- Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA.,New York Presbyterian Hospital, New York, NY, USA
| | - Andria Reyes
- Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA
| | - Alejandro Cruz
- Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA
| | - Maria Lizardo
- Northern Manhattan Improvement Corporation, New York, NY, USA
| | - Gary K Schwartz
- Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA.,Columbia University Irving Medical Center, New York, NY, USA
| | - Mary Beth Terry
- Department of Epidemiology, Mailman School of Public Health, New York, NY, USA.,Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA
| |
Collapse
|
31
|
Basch CH, Hillyer GC. Skin cancer on Instagram: implications for adolescents and young adults. Int J Adolesc Med Health 2020; 34:/j/ijamh.ahead-of-print/ijamh-2019-0218/ijamh-2019-0218.xml. [PMID: 32031976 DOI: 10.1515/ijamh-2019-0218] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2019] [Accepted: 12/29/2019] [Indexed: 11/15/2022]
Abstract
Given the popularity and reach of Instagram among American adolescents and young adults (AYA), the well-known influence of social media on the behaviors of youth, and the rising rates of melanoma in this age group, this study sought to examine and describe the content of a sample of Instagram posts related to skin cancer. At three different times, a search of Instagram was conducted using #skincancer as the hashtag. Descriptive analyses of Instagram characteristics and content was performed. Overall, content focused on prevention (33.3%), skin cancer treatment (29.3%) and preventive measures such as using sunscreen and protective gear (29.3%). Nearly one-quarter discussed the ABCDEs (Asymmetrical; Borders are irregular; Color is not even; Diameter is large; Evolving) of screening and detection. Instagram postings that covered skin cancer prevention (n = 50, 33.3%) more often discussed the role of sun exposure in the development of skin cancer (28.0% vs. 10.0%, p = 0.005) and use of sunscreen and protective gear (62.0% vs. 13.0%, p < 0.001). The findings of this study indicate that a considerable portion of the Instagram posts included in this study focused on prevention. Thus, indicating that Instagram could be used to promote health, particularly among AYA.
Collapse
Affiliation(s)
- Corey H Basch
- Department of Public Health, William Paterson University, 366 University Hall, Wayne, NJ 07470, USA, Phone: +(973)-720-2603
| | - Grace C Hillyer
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA
| |
Collapse
|
32
|
Hillyer GC, Beauchemin M, Hershman DL, Kelsen M, Brogan FL, Sandoval R, Schmitt KM, Reyes A, Terry MB, Lassman AB, Schwartz GK. Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients. Clin Trials 2020; 17:184-194. [PMID: 32009456 DOI: 10.1177/1740774520901514] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
BACKGROUND/AIMS Essential to bringing innovative cancer treatments to patients is voluntary participation in clinical trials but approximately 8% of American cancer patients are enrolled onto a trial. We used a domain-oriented framework to assess barriers to cancer clinical trial enrollment. METHODS Physicians (MD, DO, fellows, residents) and research staff (physician assistants, nurse practitioners, staff and research nurses, clinical assistants, and program coordinators) involved in clinical research at a comprehensive cancer center completed an online survey in 2017; adult cancer patients not currently enrolled in a trial were interviewed in 2018. To inform the construct of our physician/staff and patient surveys and to assess barriers to clinical trial enrollment, we first conducted in-depth interviews among 14 key informants representing medical, hematologic, gynecologic, neurologic, radiation oncology, as well as members of the clinical research team (one clinical research coordinator, one research nurse practitioner). Perceived structural, provider- and patient-level barriers to clinical trial enrollment were assessed. Differences in perceptions, attitudes, and beliefs toward clinical trial enrollment between (1) physicians and staff, (2) patients by ethnicity, and (3) physicians/staff and patients were examined. RESULTS In total, 120 physicians/staff involved in clinical research (39.2% physicians, 60.8% staff; 48.0% overall response rate) and 150 cancer patients completed surveys. Nearly three-quarters of physician/staff respondents reported difficulty in keeping track of the eligibility criteria for open studies but was more often cited by physicians than staff (84.4% vs 64.3%, p = 0.02). Physicians more often reported lack of time to present clinical trial information than did staff(p < 0.001); 44.0% of staff versus 18.2% of physicians reported patient family interaction as a clinical trial enrollment barrier (p = 0.007). Hispanic patients more often stated they would join a trial, even if standard therapy was an option compared to non-Hispanic patients (47.7% vs 20.8%, p = 0.002). Comparing the beliefs and perceptions of physicians/staff to those of patients, patients more often reported negative beliefs about clinical trial enrollment (e.g. being in a trial does not help patients personally, 32.9% vs 1.8%, p < 0.001) but less often felt they had no other options when agreeing to join (38.1% vs 85.6%, p < 0.001), and less often refused clinical trial enrollment due to lack of understanding (9.1% vs 63.3%, p = 0.001) than reported by physicians/staff. CONCLUSION Our findings indicate a wide gap between physician/staff and patient attitudes and beliefs about clinical trial enrollment and highlight the importance of focusing future initiatives to raise awareness of this incongruency. Reconciling these differences will require tailored education to reduce implicit biases and dispel misperceptions. Strategies to improve the quality of patient-provider communication and address infrastructure and resource issues are also needed to improve patient enrollment onto cancer clinical trials.
Collapse
Affiliation(s)
- Grace C Hillyer
- Department of Epidemiology, Mailman School of Public Health of Columbia University, New York, NY, USA.,Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA
| | - Melissa Beauchemin
- Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA.,New York Presbyterian Hospital, New York, NY, USA.,Columbia University School of Nursing, New York, NY, USA
| | - Dawn L Hershman
- Department of Epidemiology, Mailman School of Public Health of Columbia University, New York, NY, USA.,Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA.,Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY, USA
| | - Moshe Kelsen
- Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA
| | - Frances L Brogan
- Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA
| | - Rossy Sandoval
- Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA
| | - Karen M Schmitt
- Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA.,New York Presbyterian Hospital, New York, NY, USA
| | - Andria Reyes
- Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA
| | - Mary Beth Terry
- Department of Epidemiology, Mailman School of Public Health of Columbia University, New York, NY, USA.,Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA
| | - Andrew B Lassman
- Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA.,Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA
| | - Gary K Schwartz
- Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA.,Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY, USA
| |
Collapse
|
33
|
Quyyumi FF, Wright JD, Accordino MK, Buono D, Law CW, Hillyer GC, Neugut AI, Hershman DL. Factors Associated with Multidisciplinary Consultations in Patients with Early Stage Breast Cancer. Cancer Invest 2019; 37:233-241. [PMID: 31296072 DOI: 10.1080/07357907.2019.1624766] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Purpose: Multidisciplinary care (MDC) encourages multiple specialists to formulate a unified treatment plan. We sought to determine the frequency and predictors of MDC and assess the association between MDC and nationally-recognized quality metrics in patients with breast cancer. Methods: We used the surveillance, epidemiology, and end results-medicare dataset to evaluate patients diagnosed with stages I-III breast cancer who underwent breast-conserving surgery between 2002 and 2011 with follow-up to 2012. We defined MDC as a visit claim from a surgeon, radiation oncologist and medical oncologist within 12 months of diagnosis. We used multivariable regression analysis to determine the association between demographic and clinical variables and MDC, and to assess the association between MDC and three nationally-recognized quality indicators (adjuvant hormone therapy for hormone receptor-positive tumors, chemotherapy for hormone receptor-negative cancer, and radiation after lumpectomy). Results: Of the 61,039 patients in our initial cohort, 53,849 (88.2%) saw a medical oncologist, 46,521 (76.2%) saw a radiation oncologist, and 43,280 (70.9%) were evaluated by all three providers the first year after diagnosis. MDC use was higher in patients with the highest socioeconomic status compared with the lowest [odds ratio (OR) 1.74, 95% CI 1.63-1.86], in patients diagnosed in later years, and those with stage III disease compared to stage I [OR 1.29, 95% CI 1.19-1.41]. Patients older in age (≥80 vs. 65-69 years, OR 0.33, 95% CI 0.31-0.34), patients with more comorbidities, those who lived in a rural setting compared to urban (OR 0.61, 95% CI 0.57-0.64), and unmarried patients (OR 0.79, 95% CI 0.76-0.82) were less likely to see all three providers. In a multivariable analysis, MDC use was associated with increased likelihood of meeting each quality metric. Conclusion: Early stage breast cancer patients were evaluated by a surgeon, radiation oncologist and medical oncologist less than 75% of the time. Enhanced coordination of care and navigation programs may improve the quality of care delivered.
Collapse
Affiliation(s)
- Farah F Quyyumi
- a Department of Medicine, Columbia University College of Physicians and Surgeons , New York , New York , USA.,b Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons , New York , New York , USA
| | - Jason D Wright
- b Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons , New York , New York , USA.,c Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons , New York , New York , USA
| | - Melissa K Accordino
- a Department of Medicine, Columbia University College of Physicians and Surgeons , New York , New York , USA.,b Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons , New York , New York , USA
| | - Donna Buono
- d Department of Epidemiology, Mailman School of Public Health, Columbia University , New York , New York , USA
| | - Cynthia W Law
- d Department of Epidemiology, Mailman School of Public Health, Columbia University , New York , New York , USA
| | - Grace C Hillyer
- b Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons , New York , New York , USA.,d Department of Epidemiology, Mailman School of Public Health, Columbia University , New York , New York , USA
| | - Alfred I Neugut
- a Department of Medicine, Columbia University College of Physicians and Surgeons , New York , New York , USA.,b Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons , New York , New York , USA.,d Department of Epidemiology, Mailman School of Public Health, Columbia University , New York , New York , USA
| | - Dawn L Hershman
- a Department of Medicine, Columbia University College of Physicians and Surgeons , New York , New York , USA.,b Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons , New York , New York , USA.,d Department of Epidemiology, Mailman School of Public Health, Columbia University , New York , New York , USA
| |
Collapse
|
34
|
Basch CH, Hillyer GC, Kecojevic A, Ku CS, Basch CE. Indoor tanning and poor mental health among adolescents in New York City (2015). J Health Psychol 2019; 26:870-879. [DOI: 10.1177/1359105319852668] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
This study explored relationships between mental health and indoor tanning among high school students in New York City using 2015 data from the Youth Risk Behavior Surveillance System. Those more likely to use indoor tanning were females (odds ratio = 6.26, 95% confidence interval = 6.08–6.45) and non-Hispanic White (odds ratio = 1.10, 95% confidence interval = 1.06–1.14). Being bullied on school property (odds ratio = 1.30, 95% confidence interval = 1.25–1.34), having attempted suicide (odds ratio = 2.08, 95% confidence interval = 1.99–2.18), and having sought counseling (odds ratio = 1.22, 95% confidence interval = 1.18–1.26) were significantly associated with indoor tanning. This study indicates that engaging in indoor tanning is associated with a number of mental health factors.
Collapse
|
35
|
Li MT, Hillyer GC, Husain SA, Mohan S. Cultural barriers to organ donation among Chinese and Korean individuals in the United States: a systematic review. Transpl Int 2019; 32:1001-1018. [PMID: 30968472 DOI: 10.1111/tri.13439] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2019] [Revised: 02/11/2019] [Accepted: 04/05/2019] [Indexed: 12/22/2022]
Abstract
Asian Americans have the lowest organ donation registration rates in the United States, and the reason for this is incompletely understood. Aiming to understand the reasons for low organ donation registration rate among Asian Americans, more specifically Chinese and Korean Americans, we conducted a systematic search of databases, websites, and gray literature. Altogether, 34 papers were retained after the assessment of relevance and quality. Commonly reported barriers to organ donation registration among Chinese and Koreans in the literature included lack of knowledge about organ donation, distrust of health-care and allocation system, cultural avoidance of discussion of death-related topics, and desire for intact body mainly stemming from the Confucian concept of filial piety. Strong family values coupled with a cultural reluctance to discuss death-related topics among family members appear to underscore the reluctance to organ donation among Chinese and Koreans. Notably, improved knowledge negatively impacted organ donation intent and religion seemed to play a more important role when making decision about organ donation among Koreans, and the distrust of the allocation system is more prominent among Chinese. This information should be used to inform the development of culturally competent organ donation educational materials.
Collapse
Affiliation(s)
- Miah T Li
- Department of Medicine, Division of Nephrology, Columbia University Vagelos College of Physicians & Surgeons, New York, NY, USA.,The Columbia University Renal Epidemiology (CURE) Group, New York, NY, USA
| | - Grace C Hillyer
- Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA
| | - S Ali Husain
- Department of Medicine, Division of Nephrology, Columbia University Vagelos College of Physicians & Surgeons, New York, NY, USA.,The Columbia University Renal Epidemiology (CURE) Group, New York, NY, USA
| | - Sumit Mohan
- Department of Medicine, Division of Nephrology, Columbia University Vagelos College of Physicians & Surgeons, New York, NY, USA.,The Columbia University Renal Epidemiology (CURE) Group, New York, NY, USA.,Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA
| |
Collapse
|
36
|
Abstract
Background: Social media is a driving force in the sharing of information. The purpose of this study is to describe fluoride related content on Instagram, a popular social media platform. Methods: Content categories were created and coded to better describe the nature of the posts.Data collection occurred in three sessions, two months apart. Only relevant posts that included images and had text written in the English language were included. Results: The most common topics were conspiracy theory, contained in 37.3% of posts, followed by dangers of fluoride to health (30.3%) and benefits of fluoride to teeth (28.7%). Of the posts reviewed, 96/300 (32.0%) contained pro-fluoride content while 139/300 (63.0%) posts featured anti-fluoride content. Content varied significantly between pro- and anti-fluoride posts. Conclusion: Our review of Instagram posts revealed that there were approximately 300 posts focused on fluoride related content. Of these posts, there was a higher number of anti-fluoride related content compared to pro-fluoride related content. With accessibility comes the potential for misinformation. Future efforts from medical providers need to focus on educating consumers about reliable sources for health information on the internet.
Collapse
Affiliation(s)
- Corey H Basch
- Department of Public Health, William Paterson University, Wayne, NJ 07470, USA
| | - Nicole Milano
- School of Social Work, Rutgers University, New Brunswick, NJ 08901, USA
| | - Grace C Hillyer
- Department of Epidemiology, Mailman School of Public Health, Columbia University NY, NY 10032, USA
| |
Collapse
|
37
|
Basch CH, Hillyer GC, Romero RA, MacLean SA, Ethan D. College Students’ Attitudes and Behaviors Related to Sun Safety and Appearance in Relation to Health Information-Seeking Behavior and Social Media Use: Cross-Sectional Study. JMIR Dermatol 2018. [DOI: 10.2196/10984] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Quyyumi FF, Wright JD, Accordino MK, Buono D, Law CW, Hillyer GC, Neugut AI, Hershman DL. Factors Associated With Follow-Up Care Among Women With Early-Stage Breast Cancer. J Oncol Pract 2018; 15:e1-e9. [PMID: 30407882 DOI: 10.1200/jop.18.00229] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
PURPOSE Follow-up guidelines vary widely among national organizations for patients with early-stage breast cancer treated with curative intent. We sought to evaluate the patterns and predictors of provider follow-up care within the first 5 years after diagnosis. METHODS Using the SEER-Medicare linked data set, we evaluated patients who were diagnosed with stage I and II breast cancer who underwent breast-conserving surgery from 2002 to 2007 with follow-up until 2012. We defined discontinuation of follow-up as > 12 months from the previous physician visit without a visit claim from either a surgeon, medical oncologist, or radiation oncologist. We performed a multivariable logistic regression and Cox proportional hazards regression analysis to determine factors associated with the discontinuation of follow-up care. RESULTS Of the 30,053 patients enrolled in our initial cohort, 25,781 (85.8%) saw a medical oncologist and 21,612 (71.9%) saw a radiation oncologist in the first year in addition to a surgeon. Over the 5 years, 6,302 patients (21.0%) discontinued follow-up visits. Discontinuation of physician visits increased with increasing age. Women with stage II cancer ( v stage I) were less likely to discontinue follow-up visits (odds ratio, 0.78; 95% CI, 0.73 to 0.83). Time to early discontinuation was greater for patients with hormone receptor-negative tumors (hazard ratio, 1.14; 95% CI, 1.05 to 1.24). Women who were diagnosed more recently were less likely to discontinue seeing any physician. CONCLUSION Twenty-one percent of patients with early-stage breast cancer discontinued seeing any oncology provider over the 5 years after diagnosis. Coordination of follow-up care between oncology specialists may reduce discontinuation rates and increase clinical efficiency.
Collapse
Affiliation(s)
- Farah F Quyyumi
- 1 Columbia University College of Physicians and Surgeons, New York, NY
| | - Jason D Wright
- 1 Columbia University College of Physicians and Surgeons, New York, NY
| | | | - Donna Buono
- 2 Columbia University Mailman School of Public Health, New York, NY
| | - Cynthia W Law
- 2 Columbia University Mailman School of Public Health, New York, NY
| | - Grace C Hillyer
- 1 Columbia University College of Physicians and Surgeons, New York, NY.,2 Columbia University Mailman School of Public Health, New York, NY
| | - Alfred I Neugut
- 1 Columbia University College of Physicians and Surgeons, New York, NY.,2 Columbia University Mailman School of Public Health, New York, NY
| | - Dawn L Hershman
- 1 Columbia University College of Physicians and Surgeons, New York, NY.,2 Columbia University Mailman School of Public Health, New York, NY
| |
Collapse
|
39
|
Neugut AI, Sackstein P, Hillyer GC, Jacobson JS, Bruce J, Lassman AB, Stieg PA. Magnetic Resonance Imaging-Based Screening for Asymptomatic Brain Tumors: A Review. Oncologist 2018; 24:375-384. [PMID: 30305414 DOI: 10.1634/theoncologist.2018-0177] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2018] [Accepted: 08/09/2018] [Indexed: 12/14/2022] Open
Abstract
Brain tumors comprise 2% of all cancers but are disproportionately responsible for cancer-related deaths. The 5-year survival rate of glioblastoma, the most common form of malignant brain tumor, is only 4.7%, and the overall 5-year survival rate for any brain tumor is 34.4%. In light of the generally poor clinical outcomes associated with these malignancies, there has been interest in the concept of brain tumor screening through magnetic resonance imaging. Here, we will provide a general overview of the screening principles and brain tumor epidemiology, then highlight the major studies examining brain tumor prevalence in asymptomatic populations in order to assess the potential benefits and drawbacks of screening for brain tumors. IMPLICATIONS FOR PRACTICE: Magnetic resonance imaging (MRI) screening in healthy asymptomatic adults can detect both early gliomas and other benign central nervous system abnormalities. Further research is needed to determine whether MRI will improve overall morbidity and mortality for the screened populations and make screening a worthwhile endeavor.
Collapse
Affiliation(s)
- Alfred I Neugut
- Department of Medicine, Columbia University, New York New York, USA
- Department of Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York New York, USA
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York New York, USA
| | - Paul Sackstein
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York New York, USA
| | - Grace C Hillyer
- Department of Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York New York, USA
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York New York, USA
| | - Judith S Jacobson
- Department of Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York New York, USA
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York New York, USA
| | - Jeffrey Bruce
- Department of Neurological Surgery, Columbia University, New York New York, USA
- Department of Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York New York, USA
| | - Andrew B Lassman
- Department of Neurology, Columbia University, New York New York, USA
- Department of Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York New York, USA
| | - Philip A Stieg
- Department of Neurological Surgery, Weill-Cornell Medical College, New York New York, USA
| |
Collapse
|
40
|
Neugut AI, Zhong X, Lebwohl B, Hillyer GC, Accordino MK, Wright JD, Kiran RP, Hershman DL. Adherence to colonoscopy at 1 year following resection of localized colon cancer: a retrospective cohort study. Therap Adv Gastroenterol 2018; 11:1756284818765920. [PMID: 35154382 PMCID: PMC8832335 DOI: 10.1177/1756284818765920] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/14/2017] [Accepted: 02/01/2018] [Indexed: 02/04/2023] Open
Abstract
BACKGROUND For patients with stages I-III colon cancer who have undergone surgical resection, guidelines recommend surveillance colonoscopy at 1 year. However, limited data exist on adherence and associated factors. We aimed to determine the rate of adherence to surveillance colonoscopy at 1 year among nonmetastatic colon cancer patients who underwent resection and factors associated with adherence. METHODS In this population-based retrospective cohort study, the Surveillance, Epidemiology, and End Results (SEER)-Medicare database was used. We identified patients with stages I-III colon cancer who underwent surgical resection and survived >3 years without recurrence (no chemotherapy after 8 months) from 2002-2011. Our primary outcome was a colonoscopy claim 10-15 months after resection. We used multivariable regression analysis to assess associations between sociodemographic and clinical factors and receipt of timely colonoscopy. RESULTS Among 28,732 patients who survived >3 years without recurrence, 7967 (28%) did not undergo colonoscopy; 12,033 (42%) had it at one year, with 3159 (11%) before 10 months and 5573 (19%) after 15 months. Decreased adherence was associated with older age; being male versus female; being black or Hispanic versus white; higher tumor stage; left-sided tumors versus right sided; and increased comorbidities. Chemotherapy receipt was associated with increased adherence (odds ratio 2.06; 95% confidence interval 1.88-2.24). CONCLUSIONS In a large population-based sample of individuals aged ⩾ 65 years, only 42% of colon cancer survivors underwent 1-year surveillance colonoscopy. Demographic and clinical factors were associated with adherence.
Collapse
Affiliation(s)
- Alfred I. Neugut
- Department of Medicine, Columbia University, New
York, USA,Department of Epidemiology, Columbia University,
New York, USA,Herbert Irving Comprehensive Cancer Center,
Columbia University, New York, USA
| | - Xiaobo Zhong
- Department of Biostatistics, Columbia
University, New York, USA
| | | | - Grace C. Hillyer
- Deparment of Epidemiology, Columbia University,
New York, USA,Herbert Irving Comprehensive Cancer Center,
Columbia University, New York, USA
| | - Melissa K. Accordino
- Department of Medicine, Columbia University, New
York, USA,Herbert Irving Comprehensive Cancer Center,
Columbia University, New York, USA
| | - Jason D. Wright
- Department of Epidemiology, Columbia
University, New York, USA,Herbert Irving Comprehensive Cancer Center,
Columbia University, New York, USA,Department of Obstetrics and Gynecology,
Columbia University, New York, USA
| | - Ravi P. Kiran
- Department of Epidemiology, Columbia
University, New York, USA,Herbert Irving Comprehensive Cancer Center,
Columbia University, New York, USA,Department of Surgery, Columbia University, New
York, USA
| | - Dawn L. Hershman
- Department of Medicine, Columbia University,
New York, USA,Department of Epidemiology, Columbia
University, New York, USA,Herbert Irving Comprehensive Cancer Center,
Columbia University, New York, USA
| |
Collapse
|
41
|
Accordino MK, Wright JD, Vasan S, Neugut AI, Gross T, Hillyer GC, Hershman DL. Association between survival time with metastatic breast cancer and aggressive end-of-life care. Breast Cancer Res Treat 2017; 166:549-558. [PMID: 28752188 PMCID: PMC5695862 DOI: 10.1007/s10549-017-4420-4] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2017] [Accepted: 07/24/2017] [Indexed: 11/28/2022]
Abstract
PURPOSE For women with stage IV breast cancer (BC), the association between survival time (ST) and use of aggressive end-of-life (EOL) care is unknown. METHODS We used the SEER-Medicare database to identify women with stage IV BC diagnosed 2002-2011 who died by 12/31/2012. Aggressive EOL care was defined as receipt in the last month of life: >1 ED visit, >1 hospitalization, ICU admission, life-extending procedures, hospice admission within 3 days of death, IV chemotherapy within 14 days of death, and/or ≥10 unique physician encounters in the last 6 months of life. Receipt of aggressive EOL care and hospice in the last month of life were determined using claims, and multivariable analysis was used to identify factors associated with receipt. Costs of care were also evaluated. RESULTS We identified 4521 eligible patients. Of these, 2748 (60.8%) received aggressive EOL care. Factors associated with aggressive EOL care were race (OR 1.45, 95% CI 1.19-1.81 for blacks compared to whites) and more frequent oncology office visits (OR 1.56, 95% CI 1.28-1.90). Patients who lived >12 months after diagnosis were less likely to receive aggressive EOL care (OR 0.44, 95% CI 0.38-0.52), and more likely to utilize hospice (OR 1.43, 95% CI 1.21-1.69) compared to patients who lived ≤6 months. Patients with a shorter ST had significantly higher costs of care per-month-alive compared to patients with longer ST. CONCLUSION Patients with a shorter ST were more likely to receive aggressive EOL care and had higher costs of care compared to patients who lived longer.
Collapse
Affiliation(s)
- Melissa K Accordino
- Department of Medicine, Columbia University College of Physicians and Surgeons, 161 Ft Washington Ave, Room 9-962, New York, NY, 10032, USA.
- Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY, USA.
| | - Jason D Wright
- Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY, USA
- Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA
| | - Sowmya Vasan
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA
| | - Alfred I Neugut
- Department of Medicine, Columbia University College of Physicians and Surgeons, 161 Ft Washington Ave, Room 9-962, New York, NY, 10032, USA
- Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY, USA
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA
| | - Tal Gross
- Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York, NY, USA
| | - Grace C Hillyer
- Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY, USA
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA
| | - Dawn L Hershman
- Department of Medicine, Columbia University College of Physicians and Surgeons, 161 Ft Washington Ave, Room 9-962, New York, NY, 10032, USA
- Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY, USA
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA
| |
Collapse
|
42
|
Basch CH, Hillyer GC, Garcia P, Basch CE. Clostridium difficile on YouTube: A need for greater focus on prevention. J Infect Public Health 2017; 11:290-293. [PMID: 28851505 DOI: 10.1016/j.jiph.2017.08.003] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2017] [Accepted: 08/05/2017] [Indexed: 11/19/2022] Open
Abstract
The purpose of this study was to describe the content of the most popular YouTube videos related to Clostridium difficile. Across all sources, the kinds of content most likely to be included in the videos was general information, overuse of antibiotics, and symptomatic diarrhea. Health professionals can contribute to existing social media messages related to C. difficile with comprehensive messages that include means for prevention.
Collapse
Affiliation(s)
- Corey H Basch
- Department of Public Health, William Paterson University, Wayne, NJ 07470, United States.
| | - Grace C Hillyer
- Department of Epidemiology, Mailman School of Public Health, Columbia University, NY, NY 10032, United States
| | - Philip Garcia
- Department of Public Health, William Paterson University, Wayne, NJ 07470, United States
| | - Charles E Basch
- Health and Behavior Studies, Teachers College, Columbia University, NY, NY 10027, United States
| |
Collapse
|
43
|
Quyyumi F, Accordino MK, Buono DL, Neugut AI, Hillyer GC, Wright JD, Hershman DL. Abstract P5-13-14: Factors associated with multidisciplinary care in the management of early stage breast cancer. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p5-13-14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: In patients with early stage breast cancer (BC) treated with curative intent, multidisciplinary teams (MDT) have emerged as a way to involve a wide range of specialists and encourage effective communication to formulate an optimal treatment strategy for patients. We sought to evaluate the frequency and predictors of MDT evaluation in patients with BC.
Methods: We used the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked dataset to evaluate patients diagnosed with stages I and II breast cancer who underwent primary surgery from 2002-2007 and were followed through 2012. We evaluated claims for outpatient visits and characterized the treating physician as a surgeon, radiation oncologist (RO) or medical oncologist (MO). We defined MDT as having seen a physician in each of the three specialties within 12 months of diagnosis. We used multivariable logistic regression to evaluate factors associated with MDT.
Results: A total of 35,484 stage I and II breast cancer patients were included in the analysis. Within the first year, 77.5% visited a medical oncologist, 57.8% visited a radiation oncologist, and 47% of women were seen by all 3 specialists. Prior to surgery, 4.9% of patients were seen by all 3 physicians, with 14.8% seen by a MO and 16.4% seen by a RO in addition to the surgeon. Evaluation by a MDT was more frequent in women who had a lumpectomy vs mastectomy (57.1% vs 28.4%, p<0.0001), Caucasian race as opposed to black and Hispanic (47.4% vs 42.1% vs 37.4%, p<0.0001), those that lived in an urban setting versus rural (48.1% vs 36.25%, p<0.0001), and those that were married versus unmarried (50.8% vs 43.1%, p<0.0001). As age increased, the number of patients who saw all three physicians decreased. As socioeconomic status improved, more patients saw all three physicians. In a multivariate model, evaluation by a MDT was higher in patients with Stage II disease (OR [95% CI] = 1.10 [1.04-1.18]), diagnosed in 2006-2007 (as compared to 2002-2005) (OR = 1.73 [1.63-1.85]), and those who received chemotherapy (OR = 1.51 [1.39-1.64]) and was less likely for older women (OR = 0.77 [0.71-0.84]), those who underwent mastectomy (OR = 0.73 [0.68-0.78]), and those in the lowest socioeconomic quintile (OR = 0.88 [0.80-0.97]). Of those seen by all 3 physicians in the first year, 20.4%, 10.1%, 6.1%, and 3.9% were seen by all 3 specialists in years 2, 3, 4 and 5 respectively. Only 2.2% of patients saw all three specialists all five years.
Conclusions: Early stage breast cancer patients are evaluated by a medical oncologist, surgeon and radiation oncologist less than 50% of the time in the first year after diagnosis. Prior to surgery, where decision making may be most important, only 5% of patients were evaluated by all three specialties. Further research is needed to determine if MDT improves quality of care delivered, treatment adherence, patient satisfaction or breast cancer survival.
Citation Format: Quyyumi F, Accordino MK, Buono DL, Neugut AI, Hillyer GC, Wright JD, Hershman DL. Factors associated with multidisciplinary care in the management of early stage breast cancer [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P5-13-14.
Collapse
Affiliation(s)
- F Quyyumi
- Columbia University Medical Center, New York, NY
| | - MK Accordino
- Columbia University Medical Center, New York, NY
| | - DL Buono
- Columbia University Medical Center, New York, NY
| | - AI Neugut
- Columbia University Medical Center, New York, NY
| | - GC Hillyer
- Columbia University Medical Center, New York, NY
| | - JD Wright
- Columbia University Medical Center, New York, NY
| | - DL Hershman
- Columbia University Medical Center, New York, NY
| |
Collapse
|
44
|
Accordino MK, Wright JD, Vasan S, Neugut AI, Hillyer GC, Hershman DL. Abstract P5-08-03: Predictors of aggressive end-of-life care in women metastatic breast cancer. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p5-08-03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Despite recommendations against aggressive end-of-life (EOL) care, a high percentage of patients with metastatic breast cancer (MBC) receive aggressive EOL care. MBC is a heterogeneous disease with a wide variation in survival. EOL care may differ by the patients' long-term course of care. We performed a population-based analysis to evaluate patterns and predictors of aggressive EOL care and associated costs among women with MBC.
Methods: The Surveillance, Epidemiology, and End Results-Medicare database was used to identify female patients with MBC diagnosed between 2002 and 2011. Aggressive EOL care in the last month of life was identified using claims data. Specifically: ≥2 emergency department (ED) visits, ≥2 hospital admissions, >14 days hospitalized, admission to the intensive care unit (ICU), admission to hospice within 3 days or less before death, and receipt of intravenous (IV) chemotherapy in the last 14 days of life were evaluated. Direct healthcare costs in the last month of life were calculated from Medicare claims. Patients were categorized into prognosis quartiles based on survival time from diagnosis. Multivariable analysis was performed to identify patient characteristics associated with aggressive EOL care and characteristics associated with high direct healthcare expenditures in last month of life in women with hormone-receptor (HR)+ and HR- MBC. High expenditures were defined as median costs >75th percentile. Factors associated with high expenditures were evaluated using linear regression.
Results: We identified 5,064 eligible patients. Of these, 2,156 (42.6%) received at least one measure of aggressive EOL care in the last month of life. The most frequent aggressive EOL care received in the last month of life were ICU admissions (17.3%) and >1 ED visits (14.1%). Median cost of care in the last month of life was $7,973. Predictors of aggressive EOL care included year of diagnosis (OR 1.04, 95% CI 1.02-1.06), black race as compared to whites (OR 1.50, 95% CI 1.25-1.79), being married compared to single (OR 1.15, 95% CI 1.01-1.32), and a Charlson comorbidity score of ≥2 compared to no comorbidities (OR 1.52, 95%CI 1.32-1.75). Predictors of not receiving aggressive EOL care included age >74 compared to ages 70-74, receiving care in the Midwest compared to the East (OR 0.82, 95% CI 0.70-0.96), and best prognosis compared to worst prognosis (OR 0.46, 95% CI 0.39-0.55). Predictors of high last month of life expenditures were similar in both the HR+ and HR- subsets; receipt of more aggressive EOL care was also associated with higher expenditures in both HR subsets (OR 5.02, 95% CI 3.88-6.49; OR 5.43, 95% CI 3.41-8.65, respectively). Median last month of life expenditures were unchanged from 2002-2012 for the whole population ($7,658 to $5,910, p=0.93), but rose significantly in patients in the worst prognosis quartile ($9,236 to $16,926, p<0.0001)
Conclusion: Patients with MBC frequently received aggressive EOL care. Women with poor prognosis were more likely to receive aggressive EOL care and have higher expenditures in the last month of life. Given the rising costs of cancer care, efforts should be made to identify patients early for EOL interventions to reduce costs, particularly in women with a poor prognosis.
Citation Format: Accordino MK, Wright JD, Vasan S, Neugut AI, Hillyer GC, Hershman DL. Predictors of aggressive end-of-life care in women metastatic breast cancer [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P5-08-03.
Collapse
Affiliation(s)
- MK Accordino
- Columbia University College of Physicians and Surgeons, New York, NY; Columbia University Mailman School of Public Health
| | - JD Wright
- Columbia University College of Physicians and Surgeons, New York, NY; Columbia University Mailman School of Public Health
| | - S Vasan
- Columbia University College of Physicians and Surgeons, New York, NY; Columbia University Mailman School of Public Health
| | - AI Neugut
- Columbia University College of Physicians and Surgeons, New York, NY; Columbia University Mailman School of Public Health
| | - GC Hillyer
- Columbia University College of Physicians and Surgeons, New York, NY; Columbia University Mailman School of Public Health
| | - DL Hershman
- Columbia University College of Physicians and Surgeons, New York, NY; Columbia University Mailman School of Public Health
| |
Collapse
|
45
|
Accordino MK, Wright JD, Vasan S, Neugut AI, Hillyer GC, Hershman DL. Factors and Costs Associated With Delay in Treatment Initiation and Prolonged Length of Stay With Inpatient EPOCH Chemotherapy in Patients With Hematologic Malignancies. Cancer Invest 2017; 35:202-214. [PMID: 28165774 DOI: 10.1080/07357907.2016.1276186] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
Reducing delays related to inpatient chemotherapy may reduce healthcare costs. Using a national database, we identified patients with lymphoma/leukemia with ≥1 etoposide, vincristine, doxorubicin, cyclophosphamide, and prednisone (EPOCH) chemotherapy claim and evaluated chemotherapy initiation delay (ID), >1 day from admission. Standard tests/procedures prior to initiation were evaluated. Among 4453 inpatient cycles, 19.7% had ID, odds ratio 2.28 (95% confidence interval: 1.83-2.85) with cycle 1 compared to cycle 2, and mean costs were higher in patients with ID than without ID (p < .0001). Prior to cycle 1, patients were more likely to undergo routine diagnostic procedures compared to subsequent cycles. Efforts to perform routine procedures prior to admission may reduce hospital length of stay and costs.
Collapse
Affiliation(s)
- Melissa K Accordino
- a Department of Medicine College of Physicians and Surgeons , Columbia University , New York , NY , USA.,b Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons , Columbia University , New York , NY , USA
| | - Jason D Wright
- b Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons , Columbia University , New York , NY , USA.,c Department of Obstetrics and Gynecology, College of Physicians and Surgeons , Columbia University , New York , NY , USA
| | - Sowmya Vasan
- d Department of Epidemiology, Mailman School of Public Health , Columbia University , New York , NY , USA
| | - Alfred I Neugut
- a Department of Medicine College of Physicians and Surgeons , Columbia University , New York , NY , USA.,b Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons , Columbia University , New York , NY , USA.,d Department of Epidemiology, Mailman School of Public Health , Columbia University , New York , NY , USA
| | - Grace C Hillyer
- b Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons , Columbia University , New York , NY , USA.,d Department of Epidemiology, Mailman School of Public Health , Columbia University , New York , NY , USA
| | - Dawn L Hershman
- a Department of Medicine College of Physicians and Surgeons , Columbia University , New York , NY , USA.,b Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons , Columbia University , New York , NY , USA.,d Department of Epidemiology, Mailman School of Public Health , Columbia University , New York , NY , USA
| |
Collapse
|
46
|
Accordino MK, Wright JD, Vasan S, Neugut AI, Hillyer GC, Hu JC, Hershman DL. Use and Costs of Disease Monitoring in Women With Metastatic Breast Cancer. J Clin Oncol 2016; 34:2820-6. [PMID: 27161970 PMCID: PMC5012664 DOI: 10.1200/jco.2016.66.6313] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
PURPOSE The optimal frequency of monitoring patients with metastatic breast cancer (MBC) is unknown; however, data suggest that intensive monitoring does not improve outcomes. We performed a population-based analysis to evaluate patterns and predictors of extreme use of disease-monitoring tests (serum tumor markers [STMs] and radiographic imaging) among women with MBC. METHODS The SEER-Medicare database was used to identify women with MBC diagnosed from 2002 to 2011 who underwent disease monitoring. Billing dates of STMs (carcinoembryonic antigen and/or cancer antigen 15-3/cancer antigen 27.29) and imaging tests (computed tomography and/or positron emission tomography) were recorded; if more than one STM or imaging test were completed on the same day, they were counted once. We defined extreme use as > 12 STM and/or more than four radiographic imaging tests in a 12-month period. Multivariable analysis was used to identify factors associated with extreme use. In extreme users, total health care costs and end-of-life health care utilization were compared with the rest of the study population. RESULTS We identified 2,460 eligible patients. Of these, 924 (37.6%) were extreme users of disease-monitoring tests. Factors significantly associated with extreme use were hormone receptor-negative MBC (odds ratio [OR], 1.63; 95% CI, 1.27 to 2.08), history of a positron emission tomography scan (OR, 2.92; 95% CI, 2.40 to 3.55), and more frequent oncology office visits (OR, 3.14; 95% CI, 2.49 to 3.96). Medical costs per year were 59.2% higher in extreme users. Extreme users were more likely to use emergency department and hospice services at the end of life. CONCLUSION Despite an unknown clinical benefit, approximately one third of elderly women with MBC were extreme users of disease-monitoring tests. Higher use of disease-monitoring tests was associated with higher total health care costs. Efforts to understand the optimal frequency of monitoring are needed to inform clinical practice.
Collapse
Affiliation(s)
- Melissa K Accordino
- Melissa K. Accordino, Jason D. Wright, Alfred I. Neugut, Grace C. Hillyer, and Dawn L. Hershman, Columbia University College of Physicians and Surgeons; Sowmya Vasan, Alfred I. Neugut, Grace C. Hillyer, and Dawn L. Hershman, Columbia University; and Jim C. Hu, Weill Cornell Medicine, New York, NY.
| | - Jason D Wright
- Melissa K. Accordino, Jason D. Wright, Alfred I. Neugut, Grace C. Hillyer, and Dawn L. Hershman, Columbia University College of Physicians and Surgeons; Sowmya Vasan, Alfred I. Neugut, Grace C. Hillyer, and Dawn L. Hershman, Columbia University; and Jim C. Hu, Weill Cornell Medicine, New York, NY
| | - Sowmya Vasan
- Melissa K. Accordino, Jason D. Wright, Alfred I. Neugut, Grace C. Hillyer, and Dawn L. Hershman, Columbia University College of Physicians and Surgeons; Sowmya Vasan, Alfred I. Neugut, Grace C. Hillyer, and Dawn L. Hershman, Columbia University; and Jim C. Hu, Weill Cornell Medicine, New York, NY
| | - Alfred I Neugut
- Melissa K. Accordino, Jason D. Wright, Alfred I. Neugut, Grace C. Hillyer, and Dawn L. Hershman, Columbia University College of Physicians and Surgeons; Sowmya Vasan, Alfred I. Neugut, Grace C. Hillyer, and Dawn L. Hershman, Columbia University; and Jim C. Hu, Weill Cornell Medicine, New York, NY
| | - Grace C Hillyer
- Melissa K. Accordino, Jason D. Wright, Alfred I. Neugut, Grace C. Hillyer, and Dawn L. Hershman, Columbia University College of Physicians and Surgeons; Sowmya Vasan, Alfred I. Neugut, Grace C. Hillyer, and Dawn L. Hershman, Columbia University; and Jim C. Hu, Weill Cornell Medicine, New York, NY
| | - Jim C Hu
- Melissa K. Accordino, Jason D. Wright, Alfred I. Neugut, Grace C. Hillyer, and Dawn L. Hershman, Columbia University College of Physicians and Surgeons; Sowmya Vasan, Alfred I. Neugut, Grace C. Hillyer, and Dawn L. Hershman, Columbia University; and Jim C. Hu, Weill Cornell Medicine, New York, NY
| | - Dawn L Hershman
- Melissa K. Accordino, Jason D. Wright, Alfred I. Neugut, Grace C. Hillyer, and Dawn L. Hershman, Columbia University College of Physicians and Surgeons; Sowmya Vasan, Alfred I. Neugut, Grace C. Hillyer, and Dawn L. Hershman, Columbia University; and Jim C. Hu, Weill Cornell Medicine, New York, NY
| |
Collapse
|
47
|
Greenlee H, Neugut AI, Falci L, Hillyer GC, Buono D, Roh JM, Ergas IJ, Kwan ML, Lee M, Tsai WY, Shi Z, Lamerato L, Mandelblatt JS, Kushi LH, Hershman DL. Abstract PD4-05: Complementary and alternative medicine use and breast cancer chemotherapy initiation: The BQUAL study. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-pd4-05] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
PURPOSE: Adjuvant therapy is associated with improved survival for women with breast cancer, but not all women who could benefit initiate treatment. Women's belief systems are related to treatment initiation. It has been hypothesized that complementary and alternative (CAM) use is associated with decreased initiation of standard oncology treatments because patients may be exploring alternative treatment approaches. However, there are limited data on the association between CAM use and cancer treatment initiation. We examined the association between CAM use and initiation of adjuvant breast cancer chemotherapy in a prospective cohort of early stage breast cancer patients.
PATIENTS AND METHODS: Subjects participated in a multi-center prospective cohort study of women with early stage invasive breast cancer (n=1,156). National Comprehensive Cancer Network guidelines were used to define groups based on whether chemotherapy was indicated. Three subgroups were created: chemotherapy indicated for subjects <70 years, chemotherapy discretionary for subjects <70 years, and chemotherapy discretionary for subjects ≥70 years. CAM use was assessed based upon self-reported use of 5 CAM modalities, including vitamin/mineral supplements, herbal supplements, other over-the-counter natural products, mind-body based approaches, and body/energy-based treatments. Psychosocial factors potentially related to chemotherapy initiation were assessed. Multivariable logistic regression models evaluated the associations between CAM use and chemotherapy initiation, adjusted for demographic, clinical and psychosocial factors.
RESULTS: Current CAM use was reported by 87% of women and 38% reporting current use of ≥3 modalities. The most commonly used CAM modalities were mind body therapies (63%) and other natural products (41%). In bivariate analyses, among women <70 years where chemotherapy was indicated, women who reported current use of vitamins/minerals or current use of all 5 CAM modalities were less likely to initiate chemotherapy compared to non-users (P<.0001), but this was not observed among women for whom chemotherapy was discretionary. Psychosocial factors were also associated with high levels of current CAM use in this group, including higher expectations of adverse effects from chemotherapy, more concerns about the physical effects of chemotherapy, lower beliefs in the benefits of chemotherapy, and lower positive decision balance while making chemotherapy decisions (all P<.05). Among women age <70 years for whom chemotherapy was indicated, 89% initiated treatment, and current use of all 5 CAM modalities was inversely associated with initiation in multivariable analyses adjusted for demographic and clinical factors (OR=0.08, CI: 0.02-0.32). The association remained after separately adjusting for psychosocial factors (all P<.05), except for positive decision balance, which was no longer statistically significant.
CONCLUSIONS: High use of CAM was associated with decreased chemotherapy initiation among women with breast cancer for whom chemotherapy was indicated. It is important for oncologists to discuss CAM use with their patients, especially since high CAM use is associated with negative expectations and beliefs about chemotherapy.
Citation Format: Greenlee H, Neugut AI, Falci L, Hillyer GC, Buono D, Roh JM, Ergas IJ, Kwan ML, Lee M, Tsai WY, Shi Z, Lamerato L, Mandelblatt JS, Kushi LH, Hershman DL. Complementary and alternative medicine use and breast cancer chemotherapy initiation: The BQUAL study. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr PD4-05.
Collapse
Affiliation(s)
- H Greenlee
- Columbia University Medical Center, NY, NY; Kaiser Permanente Northern California Division of Research, Oakland, CA; University of California San Francisco, San Francisco, CA; Henry Ford Health System, Detroit, MI; Georgetown University Medical Center, Washington DC, DC
| | - AI Neugut
- Columbia University Medical Center, NY, NY; Kaiser Permanente Northern California Division of Research, Oakland, CA; University of California San Francisco, San Francisco, CA; Henry Ford Health System, Detroit, MI; Georgetown University Medical Center, Washington DC, DC
| | - L Falci
- Columbia University Medical Center, NY, NY; Kaiser Permanente Northern California Division of Research, Oakland, CA; University of California San Francisco, San Francisco, CA; Henry Ford Health System, Detroit, MI; Georgetown University Medical Center, Washington DC, DC
| | - GC Hillyer
- Columbia University Medical Center, NY, NY; Kaiser Permanente Northern California Division of Research, Oakland, CA; University of California San Francisco, San Francisco, CA; Henry Ford Health System, Detroit, MI; Georgetown University Medical Center, Washington DC, DC
| | - D Buono
- Columbia University Medical Center, NY, NY; Kaiser Permanente Northern California Division of Research, Oakland, CA; University of California San Francisco, San Francisco, CA; Henry Ford Health System, Detroit, MI; Georgetown University Medical Center, Washington DC, DC
| | - JM Roh
- Columbia University Medical Center, NY, NY; Kaiser Permanente Northern California Division of Research, Oakland, CA; University of California San Francisco, San Francisco, CA; Henry Ford Health System, Detroit, MI; Georgetown University Medical Center, Washington DC, DC
| | - IJ Ergas
- Columbia University Medical Center, NY, NY; Kaiser Permanente Northern California Division of Research, Oakland, CA; University of California San Francisco, San Francisco, CA; Henry Ford Health System, Detroit, MI; Georgetown University Medical Center, Washington DC, DC
| | - ML Kwan
- Columbia University Medical Center, NY, NY; Kaiser Permanente Northern California Division of Research, Oakland, CA; University of California San Francisco, San Francisco, CA; Henry Ford Health System, Detroit, MI; Georgetown University Medical Center, Washington DC, DC
| | - M Lee
- Columbia University Medical Center, NY, NY; Kaiser Permanente Northern California Division of Research, Oakland, CA; University of California San Francisco, San Francisco, CA; Henry Ford Health System, Detroit, MI; Georgetown University Medical Center, Washington DC, DC
| | - WY Tsai
- Columbia University Medical Center, NY, NY; Kaiser Permanente Northern California Division of Research, Oakland, CA; University of California San Francisco, San Francisco, CA; Henry Ford Health System, Detroit, MI; Georgetown University Medical Center, Washington DC, DC
| | - Z Shi
- Columbia University Medical Center, NY, NY; Kaiser Permanente Northern California Division of Research, Oakland, CA; University of California San Francisco, San Francisco, CA; Henry Ford Health System, Detroit, MI; Georgetown University Medical Center, Washington DC, DC
| | - L Lamerato
- Columbia University Medical Center, NY, NY; Kaiser Permanente Northern California Division of Research, Oakland, CA; University of California San Francisco, San Francisco, CA; Henry Ford Health System, Detroit, MI; Georgetown University Medical Center, Washington DC, DC
| | - JS Mandelblatt
- Columbia University Medical Center, NY, NY; Kaiser Permanente Northern California Division of Research, Oakland, CA; University of California San Francisco, San Francisco, CA; Henry Ford Health System, Detroit, MI; Georgetown University Medical Center, Washington DC, DC
| | - LH Kushi
- Columbia University Medical Center, NY, NY; Kaiser Permanente Northern California Division of Research, Oakland, CA; University of California San Francisco, San Francisco, CA; Henry Ford Health System, Detroit, MI; Georgetown University Medical Center, Washington DC, DC
| | - DL Hershman
- Columbia University Medical Center, NY, NY; Kaiser Permanente Northern California Division of Research, Oakland, CA; University of California San Francisco, San Francisco, CA; Henry Ford Health System, Detroit, MI; Georgetown University Medical Center, Washington DC, DC
| |
Collapse
|
48
|
Hershman DL, Kushi LH, Hillyer GC, Coromilis E, Buono D, Lamerato LE, Bovbjerg DH, Mandelblatt8 JS, Tsai WY, Jacobson JS, Wright JD, Neugut AI. Abstract PD4-04: Psychosocial factors related to interruptions in adjuvant hormonal therapy among women with breast cancer: The breast cancer quality of care study (BQUAL). Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-pd4-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background. Adjuvant hormonal therapy (HT) for hormone-sensitive breast cancer decreases risk of breast cancer recurrence and improves survival. However, some women are non-adherent to this life-saving treatment.
Methods. In a cohort of women recruited at diagnosis of breast cancer in an integrated healthcare system, we investigated factors related to HT interruption (≥90 day gap). Serial interviews were conducted at baseline and during treatment to examine psychological factors as well as sociodemographic factors, tumor characteristics, and treatment factors. A series of multivariate models assessed potential predictors of HT interruptions.
Results. Of the 569 women in our cohort who initiated HT, 137 (24%) interrupted it, including 18 (3%) who did so prior to the first follow-up interview. In a multivariate analysis of clinical and demographic factors, only household income remained associated with HT interruption (OR 0.42, 95%CI 0.24-0.76). At first follow-up, after controlling for income, race and age, lower scores on all quality of life subscales, lower scores on global treatment satisfaction, and poorer scores on the intrusive and avoidant thought subscales of the Impact of Events scale were associated with higher odds of HT interruptions (P<0.001 for all predictors). Scores on social support and on interpersonal processes of care measures were not associated with HT interruptions. However, a higher score on the single question "How often did your doctor speak too fast?" was associated with higher risk of HT interruptions (OR 1.32, p=0.02).
Conclusions: Patients under greater duress and those with lower physical, functional, emotional or social quality of life appeared to be at the highest risk of HT interruption and thus received poorer quality care. A better understanding of psychological factors that can result in poor quality care may pave the way to targeted interventions to improve adherence.
Citation Format: Hershman DL, Kushi LH, Hillyer GC, Coromilis E, Buono D, Lamerato LE, Bovbjerg DH, Mandelblatt8 JS, Tsai W-Y, Jacobson JS, Wright JD, Neugut AI. Psychosocial factors related to interruptions in adjuvant hormonal therapy among women with breast cancer: The breast cancer quality of care study (BQUAL). [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr PD4-04.
Collapse
Affiliation(s)
- DL Hershman
- Columbia University, NY, NY; Kaiser-Permanente of Northern California, Oakland, CA; Henry Ford Health System, Detroit, MI; University of Pittsburgh Cancer Institute, Pittsburgh, PA; Lombardi Comprehensive Cancer Center, Georgetown, DC
| | - LH Kushi
- Columbia University, NY, NY; Kaiser-Permanente of Northern California, Oakland, CA; Henry Ford Health System, Detroit, MI; University of Pittsburgh Cancer Institute, Pittsburgh, PA; Lombardi Comprehensive Cancer Center, Georgetown, DC
| | - GC Hillyer
- Columbia University, NY, NY; Kaiser-Permanente of Northern California, Oakland, CA; Henry Ford Health System, Detroit, MI; University of Pittsburgh Cancer Institute, Pittsburgh, PA; Lombardi Comprehensive Cancer Center, Georgetown, DC
| | - E Coromilis
- Columbia University, NY, NY; Kaiser-Permanente of Northern California, Oakland, CA; Henry Ford Health System, Detroit, MI; University of Pittsburgh Cancer Institute, Pittsburgh, PA; Lombardi Comprehensive Cancer Center, Georgetown, DC
| | - D Buono
- Columbia University, NY, NY; Kaiser-Permanente of Northern California, Oakland, CA; Henry Ford Health System, Detroit, MI; University of Pittsburgh Cancer Institute, Pittsburgh, PA; Lombardi Comprehensive Cancer Center, Georgetown, DC
| | - LE Lamerato
- Columbia University, NY, NY; Kaiser-Permanente of Northern California, Oakland, CA; Henry Ford Health System, Detroit, MI; University of Pittsburgh Cancer Institute, Pittsburgh, PA; Lombardi Comprehensive Cancer Center, Georgetown, DC
| | - DH Bovbjerg
- Columbia University, NY, NY; Kaiser-Permanente of Northern California, Oakland, CA; Henry Ford Health System, Detroit, MI; University of Pittsburgh Cancer Institute, Pittsburgh, PA; Lombardi Comprehensive Cancer Center, Georgetown, DC
| | - JS Mandelblatt8
- Columbia University, NY, NY; Kaiser-Permanente of Northern California, Oakland, CA; Henry Ford Health System, Detroit, MI; University of Pittsburgh Cancer Institute, Pittsburgh, PA; Lombardi Comprehensive Cancer Center, Georgetown, DC
| | - W-Y Tsai
- Columbia University, NY, NY; Kaiser-Permanente of Northern California, Oakland, CA; Henry Ford Health System, Detroit, MI; University of Pittsburgh Cancer Institute, Pittsburgh, PA; Lombardi Comprehensive Cancer Center, Georgetown, DC
| | - JS Jacobson
- Columbia University, NY, NY; Kaiser-Permanente of Northern California, Oakland, CA; Henry Ford Health System, Detroit, MI; University of Pittsburgh Cancer Institute, Pittsburgh, PA; Lombardi Comprehensive Cancer Center, Georgetown, DC
| | - JD Wright
- Columbia University, NY, NY; Kaiser-Permanente of Northern California, Oakland, CA; Henry Ford Health System, Detroit, MI; University of Pittsburgh Cancer Institute, Pittsburgh, PA; Lombardi Comprehensive Cancer Center, Georgetown, DC
| | - AI Neugut
- Columbia University, NY, NY; Kaiser-Permanente of Northern California, Oakland, CA; Henry Ford Health System, Detroit, MI; University of Pittsburgh Cancer Institute, Pittsburgh, PA; Lombardi Comprehensive Cancer Center, Georgetown, DC
| |
Collapse
|
49
|
Neugut AI, Hillyer GC, Kushi LW, Lamerato L, Shim J, Bovberg DH, Nathanson D, Ambrisone CB, Mandelblatt JS, Magai C, Tsai WY, Jacobson JS, Hershman DL. Abstract P1-11-09: Early discontinuation of adjuvant chemotherapy in women with early stage breast cancer: The BQUAL study. Cancer Res 2015. [DOI: 10.1158/1538-7445.sabcs14-p1-11-09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
BACKGROUND
Adjuvant chemotherapy for early stage breast cancer decreases recurrence and increases survival. However, early discontinuation of chemotherapy occurs frequently and has a negative influence on patient outcomes.
METHODS
The Breast Cancer Quality of Care Study (BQUAL) is a prospective cohort study designed to investigate factors associated with early discontinuation of adjuvant chemotherapy among women diagnosed with non-metastatic breast cancer at three sites in the U.S between 2006 and 2010 (Columbia University Medical Center, Kaiser-Permanente of Northern California, Henry Ford Health System). Chemotherapy regimens were classified based on NCCN guidelines. Regimens were further categorized as standard and non-standard/experimental. Early discontinuation for standard treatments was defined as missing 20% of the recommended number of treatments for the prescribed regimen. We used multivariate analysis to examine the association between early discontinuation and sociodemographic factors, tumor characteristics, and baseline psychosocial factors.
RESULTS
Of 1157 women recruited, 478 patients initiated chemotherapy; 35 women received non-standard/experimental chemotherapy and an additional 17 did not complete all interviews and were excluded from the analysis. Of the remaining 426 patients, 59 (13.9%) did not complete the full course of prescribed chemotherapy. In multivariate analysis, compared to those who completed their full prescribed course of adjuvant chemotherapy, those who discontinued were more often >50 years of age (p=0.04). Early discontinuation of chemotherapy was less likely among Asian women (OR 0.12, 95% CI 0.01-0.96), those who held positive beliefs related to the efficacy of chemotherapy (OR 0.43, 95% CI 0.22-0.81), and those who were more optimistic (OR 0.93, 95% CI 0.86-0.99). Women prescribed chemotherapy regimens that had more cycles (>5 cycles) or contained paclitaxel/docetaxel were significantly more likely (OR 7.54, 95% CI 2.68-21.20 and OR 5.02, 95% CI 1.59-15.83, respectively) to discontinue chemotherapy treatment early than regimens with 6 or less cycles.
CONCLUSIONS
Women prescribed longer regimens were significantly more likely not to complete the full course. Positive beliefs about the efficacy of treatment were associated with continuation of treatment. Educational interventions focused on the importance of completing therapy may increase chemotherapy adherence.
Citation Format: Alfred I Neugut, Grace C Hillyer, Lawrence W Kushi, Lois Lamerato, Jinjoo Shim, Dana H Bovberg, David Nathanson, Christine B Ambrisone, Jeanne S Mandelblatt, Carol Magai, Wei Yann Tsai, Judith S Jacobson, Dawn L Hershman. Early discontinuation of adjuvant chemotherapy in women with early stage breast cancer: The BQUAL study [abstract]. In: Proceedings of the Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2014 Dec 9-13; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2015;75(9 Suppl):Abstract nr P1-11-09.
Collapse
Affiliation(s)
- Alfred I Neugut
- 1Columbia University Medical Center
- 2Kaiser Permanente of Northern California
| | | | | | | | | | | | | | | | | | | | | | | | - Dawn L Hershman
- 1Columbia University Medical Center
- 2Kaiser Permanente of Northern California
| |
Collapse
|